<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Amoxicillin and clavulanate: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Amoxicillin and clavulanate: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Amoxicillin and clavulanate: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="8676" href="/d/html/8676.html" rel="external">see "Amoxicillin and clavulanate: Drug information"</a> and <a class="drug drug_patient" data-topicid="10900" href="/d/html/10900.html" rel="external">see "Amoxicillin and clavulanate: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F134614"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Augmentin;</li>
<li>Augmentin ES-600</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52865910"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>AG-Amoxi Clav;</li>
<li>APO-Amoxi Clav;</li>
<li>AURO-Amoxiclav;</li>
<li>Clavulin;</li>
<li>Clavulin-125F;</li>
<li>Clavulin-250F;</li>
<li>Clavulin-500F;</li>
<li>JAMP-Amoxi Clav;</li>
<li>M-Amoxi Clav;</li>
<li>PRO-Amoxi Clav;</li>
<li>SANDOZ Amoxi-Clav</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1045068"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antibiotic, Beta-lactam and Beta-lactamase Inhibitor Combination</span>;</li>
<li>
<span class="list-set-name">Antibiotic, Penicillin</span></li></ul></div>
<div class="block don drugH1Div" id="F53462366"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage guidance: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosing:</b> Dose is based on amoxicillin component.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosage form information:</b> Not all products are interchangeable; using a product with the incorrect amoxicillin:clavulanate ratio could result in subtherapeutic clavulanate concentrations or severe diarrhea. Incidence of diarrhea appears to increase with clavulanate dose; some experts recommend not exceeding 10 mg clavulanate/kg/<b>day</b> when possible (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-36112500']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-36112500'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>General dosing:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Oral: Neonates: 15 mg amoxicillin/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">IV [Canadian product; not available in United States]: Neonates:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>5:1 formulation:</i> IV: 25 mg amoxicillin/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>10:1 formulation</i>: IV: 50 mg amoxicillin/kg/dose every 12 hours.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="483ae22b-882e-41d9-8fd3-30f4bcdc8fb8">High-dose regimen for oral step-down treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>High-dose regimen for oral step-down treatment (eg, culture-negative sepsis, susceptible <i>Escherichia coli</i> infection): </b></p>
<p style="text-indent:-2em;margin-left:4em;">Neonates weighing ≥2 kg: Oral: 25 mg amoxicillin/kg/dose every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-35355215']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-35355215'])">Ref</a></span>). <b>Note: </b>In the clinical study, the product used was the 4:1 amoxicillin:clavulanate ratio product; however, this resulted in daily clavulanate doses of 18.75 mg/kg/day; changes in defecation patterns were noted in 24% of patients in both the amoxicillin/clavulanate and the IV antibiotics groups (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-35355215']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-35355215'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F134628"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage guidance:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosing:</b> Dose is based on amoxicillin component; not all products are interchangeable; using a product with the incorrect amoxicillin:clavulanate ratio could result in subtherapeutic clavulanic acid concentrations or severe diarrhea. Incidence of diarrhea increases with clavulanate dose; some experts recommend not exceeding 10 mg clavulanate/kg/<b>day</b> or 125 mg clavulanate/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28438923','lexi-content-ref-36112500']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28438923','lexi-content-ref-36112500'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;">Formulation should be chosen based on dosing strategy:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>"Standard-dose" regimens (ie, ≤45 mg/kg/day):</i></p>
<p style="text-indent:-2em;margin-left:6em;">2:1 formulations: amoxicillin 250 mg/clavulanate 125 mg. <b>Note:</b> Per the manufacturer, the amoxicillin 250 mg/clavulanate 125 mg tablet should only be used in patients ≥40 kg, due to the amoxicillin to clavulanate ratio.</p>
<p style="text-indent:-2em;margin-left:6em;">4:1 formulations:</p>
<p style="text-indent:-2em;margin-left:8em;">• amoxicillin 125 mg/clavulanate 31.25 mg</p>
<p style="text-indent:-2em;margin-left:8em;">• amoxicillin 250 mg/clavulanate 62.5 mg</p>
<p style="text-indent:-2em;margin-left:8em;">• amoxicillin 500 mg/clavulanate 125 mg.</p>
<p style="text-indent:-2em;margin-left:6em;">7:1 formulations:</p>
<p style="text-indent:-2em;margin-left:8em;">• amoxicillin 200 mg/clavulanate 28.5 mg</p>
<p style="text-indent:-2em;margin-left:8em;">• amoxicillin 400 mg/clavulanate 57 mg</p>
<p style="text-indent:-2em;margin-left:8em;">• amoxicillin 875 mg/clavulanate 125 mg.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>"High-dose" regimens (ie, 80 to 90 mg/kg/day):</i></p>
<p style="text-indent:-2em;margin-left:6em;">14:1 formulations: amoxicillin 600 mg/clavulanate 42.9 mg.</p>
<p style="text-indent:-2em;margin-left:6em;">16:1 formulations (extended release): amoxicillin 1,000 mg/clavulanate 62.5 mg.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>General dosing: Note:</b> See indication-specific dosing; recommended doses may vary. General dosing determined by formulation amoxicillin:clavulanate ratio.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Immediate-release formulations</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">Infants, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:8em;">4:1 formulation: Oral: 20 to 40 mg amoxicillin/kg/day in divided doses every 8 hours; maximum daily dose: 1,500 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-AAP.2021'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">7:1 formulation: Oral: 25 to 45 mg amoxicillin/kg/day in divided doses every 12 hours; maximum daily dose: 1,750 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-AAP.2021'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">14:1 formulation: Oral: 90 mg amoxicillin/kg/day in divided doses every 12 hours; maximum daily dose: 4,000 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-AAP.2021'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Extended-release formulation (16:1):</i> Children and Adolescents ≥40 kg: Oral: 2,000 mg amoxicillin every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1'])">Ref</a></span>).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c00357b8-de45-4183-8d7b-6cc88f991ddf">Impetigo</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Impetigo:</b> Infants, Children, and Adolescents: Oral: 25 to 45 mg amoxicillin/kg/day in divided doses every 8 to 12 hours for 7 days. Maximum dose: Every-8-hour dosing: 500 mg amoxicillin/dose; every-12-hour dosing: 875 mg amoxicillin/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-2667333','lexi-content-ref-6660847','lexi-content-ref-30777258','lexi-content-ref-25250996','lexi-content-ref-24973422','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-2667333','lexi-content-ref-6660847','lexi-content-ref-30777258','lexi-content-ref-25250996','lexi-content-ref-24973422','lexi-content-ref-manu.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5285a396-852e-4b3d-b4b0-d754f216f7be">Osteoarticular infection, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Osteoarticular infection, acute (eg, septic [bacterial] arthritis, osteomyelitis): </b>
<i>Step-down therapy following parenteral treatment (targeted therapy for susceptible pathogen):</i> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents: Oral: 120 mg amoxicillin/kg/day in divided doses every 6 to 8 hours; maximum daily dose: 3,000 mg amoxicillin/<b>day; </b>do not exceed 125 mg of <b>clavulanate</b> per dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28708801']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28708801'])">Ref</a></span>). Minimum total duration (IV plus oral therapy) is 2 to 3 weeks for septic arthritis and 3 to 4 weeks for osteomyelitis; however, duration should be individualized based on several factors including causative pathogen, response to therapy, and normalization of inflammatory markers (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28708801','lexi-content-ref-34350458']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28708801','lexi-content-ref-34350458'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a96b8104-65d0-48ba-b460-4308464e6db6">Otitis media, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute (AOM):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>High-dose regimen: </i>
<b>Note: </b>Preferred in the United States and when activity against penicillin-nonsusceptible <i>Streptococcus pneumoniae </i>is desired (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-31505007','lexi-content-ref-21334779']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-31505007','lexi-content-ref-21334779'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months, Children, and Adolescents: Oral suspension (600 mg per 5 mL; 14:1 ratio product): Oral: 80 to 90 mg amoxicillin/kg/day divided every 12 hours. Maximum dose has not been established for AOM; however, 4,000 mg/<b>day</b> has been suggested (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-Bradley.1','lexi-content-ref-23039319','lexi-content-ref-21334779','lexi-content-ref-AAP.2021','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-Bradley.1','lexi-content-ref-23039319','lexi-content-ref-21334779','lexi-content-ref-AAP.2021','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Standard-dose regimen:</i>
<b>Note: </b>Only for use in areas where rates of penicillin-nonsusceptible <i>S. pneumoniae</i> are known to be low (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-9951971','lexi-content-ref-15286214','lexi-content-ref-31505007','lexi-content-ref-21334779','lexi-content-ref-33419114']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-9951971','lexi-content-ref-15286214','lexi-content-ref-31505007','lexi-content-ref-21334779','lexi-content-ref-33419114'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months, Children, and Adolescents: Standard formulations (4:1 or 7:1 ratio products): Oral: 40 to 45 mg amoxicillin/kg/day in divided doses every 8 to 12 hours. Maximum daily dose: 1,750 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-9951971','lexi-content-ref-9154538','lexi-content-ref-AAP.2021','lexi-content-ref-33419114','lexi-content-ref-21226577','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-9951971','lexi-content-ref-9154538','lexi-content-ref-AAP.2021','lexi-content-ref-33419114','lexi-content-ref-21226577','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Duration of therapy: </i>For patients with severe or recurrent AOM, tympanic membrane perforation, or who are &lt;2 years of age, treat for 10 days; for patients ≥2 years of age with mild to moderate, nonrecurrent disease without tympanic membrane perforation, shorter durations of 5 to 7 days may be sufficient (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-28002709','lexi-content-ref-20824827','lexi-content-ref-31876601','lexi-content-ref-NICE.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-28002709','lexi-content-ref-20824827','lexi-content-ref-31876601','lexi-content-ref-NICE.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Canadian recommendations</i>: <b>Note: </b>A higher-ratio amoxicillin and clavulanate product (ie, 14:1 ratio, the amoxicillin 600 mg and clavulanate 42.9 mg per 5 mL product) is not available in Canada; the following dosing is recommended to target middle ear concentrations similar to those achieved with the high-dose regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26941560']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26941560'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥6 months and Children:</p>
<p style="text-indent:-2em;margin-left:8em;">≤35 kg: Oral suspension (amoxicillin 400 mg and clavulanate 57 mg per 5 mL): Oral: 45 to 60 mg amoxicillin/kg/day in divided doses every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26941560']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26941560'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">&gt;35 kg: Tablet (amoxicillin 500 mg and clavulanate 125 mg per tablet): Oral: 500 mg amoxicillin every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26941560']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26941560'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Duration of therapy: For patients with severe or recurrent AOM, tympanic membrane perforation, or who are &lt;2 years of age, treat for 10 days; for patients ≥2 years of age with mild to moderate, nonrecurrent disease without tympanic membrane perforation, shorter durations of 5 to 7 days may be sufficient (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-28002709','lexi-content-ref-20824827','lexi-content-ref-26941560','lexi-content-ref-31876601','lexi-content-ref-NICE.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-28002709','lexi-content-ref-20824827','lexi-content-ref-26941560','lexi-content-ref-31876601','lexi-content-ref-NICE.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ed599b2f-52de-47cd-b7d2-d706008b1db0">Pneumonia, community-acquired</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumonia, community-acquired:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥3 months, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Empiric therapy:</i> Oral: 90 mg amoxicillin/kg/day in divided doses every 12 hours; maximum daily dose: 4,000 mg amoxicillin/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>H. influenzae, beta-lactamase-positive strains; mild infection or step-down therapy:</i></p>
<p style="text-indent:-2em;margin-left:8em;">
<i>Standard-dose regimen:</i> Oral: 45 mg amoxicillin/kg/day in divided doses every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">
<i>High-dose regimen:</i> Oral: 90 mg amoxicillin/kg/day in divided doses every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Duration of therapy:</i> For outpatient treatment of uncomplicated disease in patients who respond to therapy, 5 days of therapy is likely adequate (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33683325','lexi-content-ref-32525203','lexi-content-ref-35040920']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33683325','lexi-content-ref-32525203','lexi-content-ref-35040920'])">Ref</a></span>). Longer duration (eg, total course of 7 to 10 days) may be necessary in patients who do not respond quickly to therapy or who have underlying comorbidities (eg, lung disease, immunosuppression) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-35579504','lexi-content-ref-32525203']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-35579504','lexi-content-ref-32525203'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1437b55a-5145-4c15-bba4-c28709c37109">Rhinosinusitis, acute bacterial</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rhinosinusitis, acute bacterial:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥3 months: Oral: 45 mg amoxicillin/kg/day in divided doses every 12 hours <b>or </b>40 mg/kg/day in divided doses every 8 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Standard-dose regimen:</i> Oral: 45 mg amoxicillin/kg/day in divided doses every 12 hours; maximum dose: 875 mg amoxicillin/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22438350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22438350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>High-dose regimen:</i>
<b>Note:</b> Recommended for patients who live in areas with high endemic rates of penicillin-nonsusceptible <i>S. pneumoniae</i>, have moderate to severe infections, attend daycare, are &lt;2 years of age, were recently hospitalized, received antibiotics within the past month, or are immunocompromised, and/or if initial therapy fails (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23796742','lexi-content-ref-22438350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23796742','lexi-content-ref-22438350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">Oral: 80 to 90 mg amoxicillin/kg/day in divided doses every 12 hours; maximum dose: 2,000 mg amoxicillin/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23796742','lexi-content-ref-22438350','lexi-content-ref-19014842']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23796742','lexi-content-ref-22438350','lexi-content-ref-19014842'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Duration of therapy:</i> Limited data exist to determine optimal duration; historically 10 days has been recommended, but recently some have suggested a duration as short as 5 days; some patients may require extended therapy (ie, 14 to 21 days) based on clinical resolution (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23796742','lexi-content-ref-Bradley.1','lexi-content-ref-22438350','lexi-content-ref-NICE.2017','lexi-content-ref-34118486']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23796742','lexi-content-ref-Bradley.1','lexi-content-ref-22438350','lexi-content-ref-NICE.2017','lexi-content-ref-34118486'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7f382002-7265-4ae3-8486-c4b6f297062d">Streptococcus, group A; chronic carriage</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Streptococcus, group A; chronic carriage:</b> Limited data available: <b>Note:</b> Most individuals with chronic carriage do not require antibiotic treatment (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22965026']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22965026'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 40 mg amoxicillin/kg/day in divided doses every 8 hours for 10 days; maximum daily dose: 2,000 mg amoxicillin/<b>day </b>(<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22965026','lexi-content-ref-3135377']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22965026','lexi-content-ref-3135377'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5ac615e6-688a-461c-8a9f-5e7703d06ac9">Urinary tract infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary tract infection:</b> Infants ≥2 months, Children, and Adolescents: Oral: 20 to 45 mg amoxicillin/kg/day in divided doses every 8 to 12 hours; maximum dose: 500 mg amoxicillin/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21873693','lexi-content-ref-29292282','lexi-content-ref-25477258','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21873693','lexi-content-ref-29292282','lexi-content-ref-25477258','lexi-content-ref-manu.1'])">Ref</a></span>). Duration of therapy should be individualized based on patient age, severity/extent of infection, and clinical response; typical duration is 7 to 14 days, though it may be as short as 3 to 5 days (eg, for uncomplicated cystitis in patients ≥2 years of age) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31958969','lexi-content-ref-29292282','lexi-content-ref-32364593','lexi-content-ref-34860955','lexi-content-ref-25477258']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31958969','lexi-content-ref-29292282','lexi-content-ref-32364593','lexi-content-ref-34860955','lexi-content-ref-25477258'])">Ref</a></span>).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>IV dosing </b>
<b>(Canadian labeling; not available in United States):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Choice of formulation depends upon desired dosages of amoxicillin and clavulanate; for higher daily doses of amoxicillin (as may be used in the empiric coverage of <i>Streptococcus pneumoniae</i>), the 10:1 formulation is preferred to avoid unnecessary high clavulanate exposure.</p>
<p style="text-indent:-2em;margin-left:6em;">5:1 formulation:</p>
<p style="text-indent:-2em;margin-left:8em;">Infants &lt;3 months or weighing &lt;4 kg: IV: 25 mg amoxicillin/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Infants ≥3 months weighing ≥4 kg, Children, and Adolescents: IV: 25 mg amoxicillin/kg/dose every 8 hours; maximum dose: 1,000 mg amoxicillin/dose.</p>
<p style="text-indent:-2em;margin-left:6em;">10:1 formulation:</p>
<p style="text-indent:-2em;margin-left:8em;">Infants &lt;3 months or weighing &lt;4 kg: IV: 50 mg amoxicillin/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Infants ≥3 months, Children, and Adolescents weighing 4 to &lt;40 kg: 50 mg amoxicillin/kg/dose every 8 hours; maximum dose: 2,000 mg amoxicillin/dose.</p>
<p style="text-indent:-2em;margin-left:8em;">Children and Adolescents weighing ≥40 kg: 2,000 mg amoxicillin every 8 to 12 hours.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dorp drugH1Div" id="F51064793"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral: </b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents: There are no dosage adjustments provided in the manufacturer's labeling; however, the following has been used by some clinicians (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Aronoff.2007']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Aronoff.2007'])">Ref</a></span>). The manufacturer recommends to avoid the 875 mg immediate-release tablets and extended-release tablets if GFR &lt;30 mL/minute.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Standard-dose regimens:</i> Dosing based on 20 to 40 mg amoxicillin/kg/day divided every 8 hours or 25 to 45 mg amoxicillin/kg/day divided every 12 hours:</p>
<p style="text-indent:-2em;margin-left:8em;">GFR ≥30 mL/minute/1.73 m<sup>2</sup>: No adjustment required.</p>
<p style="text-indent:-2em;margin-left:8em;">GFR 10 to 29 mL/minute/1.73 m<sup>2</sup>: Oral: 8 to 20 mg amoxicillin/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">GFR &lt;10 mL/minute/1.73 m<sup>2</sup>: Oral: 8 to 20 mg amoxicillin/kg/dose every 24 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Hemodialysis: Oral: 8 to 20 mg amoxicillin/kg/dose every 24 hours; give after dialysis.</p>
<p style="text-indent:-2em;margin-left:8em;">Peritoneal dialysis: Oral: 8 to 20 mg amoxicillin/kg/dose every 24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>High-dose regimens</i>: Dosing based on 80 to 90 mg amoxicillin/kg/day divided every 12 hours:</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &gt;30 mL/minute/1.73 m<sup>2</sup>: No adjustment required.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl 10 to 29 mL/minute/1.73 m<sup>2</sup>: Oral: 20 mg amoxicillin/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &lt;10 mL/minute/1.73 m<sup>2</sup>: Oral: 20 mg amoxicillin/kg/dose every 24 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Hemodialysis: Oral: 20 mg amoxicillin/kg/dose every 24 hours; give after dialysis.</p>
<p style="text-indent:-2em;margin-left:8em;">Peritoneal dialysis: Oral: 20 mg amoxicillin/kg/dose every 24 hours.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>IV</b> [Canadian product]:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>5:1 formulation:</i></p>
<p style="text-indent:-2em;margin-left:6em;">Infants, Children, and Adolescents weighing &lt;40 kg:</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &gt;30 mL/minute: No dosage adjustment necessary.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl 10 to 30 mL/minute: IV: 25 mg amoxicillin/kg every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &lt;10 mL/minute: IV: 25 mg amoxicillin/kg every 24 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Hemodialysis: IV: 25 mg amoxicillin/kg every 24 hours; give an additional dose of 12.5 mg amoxicillin/kg at the end of each dialysis session.</p>
<p style="text-indent:-2em;margin-left:6em;">Children and Adolescents weighing ≥40 kg:</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &gt;30 mL/minute: No dosage adjustment necessary.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl 10 to 30 mL/minute: IV: 1,000 mg amoxicillin followed by 500 mg amoxicillin every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &lt;10 mL/minute: IV: 1,000 mg amoxicillin followed by 500 mg amoxicillin every 24 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Hemodialysis: IV: 1,000 mg amoxicillin followed by 500 mg amoxicillin every 24 hours; give an additional 500 mg at the end of each dialysis session.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>10:1 formulation:</i></p>
<p style="text-indent:-2em;margin-left:6em;">Infants, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &gt;30 mL/minute: No dosage adjustment necessary.</p>
<p style="text-indent:-2em;margin-left:8em;">CrCl &lt;30 mL/minute: Use not recommended due to lack of data; preferred formulation is 5:1 with this level of kidney impairment.</p></div>
<div class="block dohp drugH1Div" id="F51064794"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution. Use is contraindicated in patients with a history of amoxicillin and clavulanate-associated hepatic dysfunction.</p></div>
<div class="block doa drugH1Div" id="F134618"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="8676" href="/d/html/8676.html" rel="external">see "Amoxicillin and clavulanate: Drug information"</a>)</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage guidance:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosing: </b>Dose is based on the amoxicillin component.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Dosage form information:</b> Dose and frequency are product specific; not all products are interchangeable. For adults who have difficulty swallowing the tablets, oral suspension in the appropriate amount may be given.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Usual dosing range:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> Immediate release: 500 mg every 8 to 12 hours <b>or</b> 875 mg every 12 hours; Extended release: 2 g every 12 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>IV</b> [Canadian product]: 1 g every 8 hours or 2 g every 8 to 12 hours; surgical prophylaxis: 1 to 2 g at induction of anesthesia for procedures &lt;1 hour (for procedures &gt;1 hour may administer up to 2 additional doses in 24 hours; do not exceed 3 g in 24 hours).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="bb1f0aaf-41ff-4651-ad53-d81e2f072c7d">Bite wound infection, prophylaxis or treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bite wound infection, prophylaxis or treatment (animal or human bite) (off-label use):</b>
<b>Oral:</b> Immediate release: 875 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24973422']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24973422'])">Ref</a></span>). For prophylaxis, duration is 3 to 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24973422']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24973422'])">Ref</a></span>); for treatment of established infection, duration is typically 5 to 14 days and varies based on clinical response and patient-specific factors (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Baddour.2021a','lexi-content-ref-Baddour.2021b']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Baddour.2021a','lexi-content-ref-Baddour.2021b'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="bbd52e21-dcfe-472c-a480-3587971723ab">Chronic obstructive pulmonary disease, acute exacerbation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Chronic obstructive pulmonary disease, acute exacerbation:</b>
<b>Note:</b> Some experts reserve for patients with risk factors for poor outcomes (eg, ≥65 years of age, FEV<sub>1</sub> &lt;50% predicted, frequent exacerbations, major comorbidities), but low risk of <i>Pseudomonas</i> infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Sethi.2020']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Sethi.2020'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> Immediate release: 500 mg every 8 hours <b>or</b> 875 mg every 12 hours for 5 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Gold.2021','lexi-content-ref-22923662','lexi-content-ref-22135277']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Gold.2021','lexi-content-ref-22923662','lexi-content-ref-22135277'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c82d3ece-50d0-49c2-ae32-3a2c16f1d66e">Diabetic foot infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Diabetic foot infection (off-label use): </b>
<b>Note: </b>May be used alone for mild infections or after clinical response to parenteral therapy in patients without risk factors or concern for infection caused by <i>Pseudomonas aeruginosa</i> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22619242']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22619242'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> Immediate release: 875 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22619242','lexi-content-ref-14679443','lexi-content-ref-Weintrob.2018']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22619242','lexi-content-ref-14679443','lexi-content-ref-Weintrob.2018'])">Ref</a></span>). Duration of therapy depends on severity and clinical response; most patients with infection limited to skin and soft tissue respond to 1 to 2 weeks of therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22619242']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22619242'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c9474c76-c81a-48ef-b80f-72ce1a0e25f5">Intra-abdominal infection, mild to moderate, community-acquired in patients without risk factors for resistance or treatment failure</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Intra-abdominal infection, mild to moderate, community-acquired in patients without risk factors for resistance or treatment failure (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Diverticulitis, acute (for uncomplicated infection that meets criteria <i>
<b>for outpatient therapy or as step-down therapy after clinical improvement on initial parenteral therapy)</b></i>:</i></b></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note:</b> Some experts suggest deferring antibiotics in otherwise healthy patients who are immunocompetent with mild disease (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26453777','lexi-content-ref-30664553','lexi-content-ref-34183510','lexi-content-ref-28719679','lexi-content-ref-28085573','lexi-content-ref-32073652']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26453777','lexi-content-ref-30664553','lexi-content-ref-34183510','lexi-content-ref-28719679','lexi-content-ref-28085573','lexi-content-ref-32073652'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Immediate release: <b>Oral:</b> 875 mg every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23732265','lexi-content-ref-32434733','lexi-content-ref-24192258','lexi-content-ref-34183510']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23732265','lexi-content-ref-32434733','lexi-content-ref-24192258','lexi-content-ref-34183510'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Extended release: <b>Oral:</b> 2 g every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Pemberton.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Pemberton.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>
<b>Other intra-abdominal infection, step-down therapy (when clinically improved and able to tolerate oral therapy)</b>
<b>:</b></i>
<b>Oral:</b> Immediate release: 875 mg 2 to 3 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Barshak.1','lexi-content-ref-18555934','lexi-content-ref-28085573','lexi-content-ref-20034345']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Barshak.1','lexi-content-ref-18555934','lexi-content-ref-28085573','lexi-content-ref-20034345'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Duration:</i></b> Total duration of therapy is 4 to 5 days following adequate source control (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25992746','lexi-content-ref-28085573']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25992746','lexi-content-ref-28085573'])">Ref</a></span>). For diverticulitis or uncomplicated appendicitis managed without intervention, duration is 10 to 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Barshak.1','lexi-content-ref-Pemberton.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Barshak.1','lexi-content-ref-Pemberton.1'])">Ref</a></span>); for perforated appendicitis managed with laparoscopic appendectomy, 2 to 4 days may be sufficient (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-36669519','lexi-content-ref-25992746']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-36669519','lexi-content-ref-25992746'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="66f4bb96-e030-4d8a-80c4-ec2d39cf0ca8">Neutropenic fever, low-risk patients with cancer</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Neutropenic fever, low-risk patients with cancer (empiric therapy) (off-label use):</b>
<b>Oral:</b> Immediate release: 500 mg every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-10423464','lexi-content-ref-10423465']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-10423464','lexi-content-ref-10423465'])">Ref</a></span>) <b>or</b> 875 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23358983']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23358983'])">Ref</a></span>). Combine either dosing regimen with oral ciprofloxacin; continue until resolution of fever and neutropenia. <b>Note:</b> Avoid in patients who have received fluoroquinolone prophylaxis. Administer first dose in the health care setting (after blood cultures are drawn); observe patient for ≥4 hours before discharge (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29461916','lexi-content-ref-21258094']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29461916','lexi-content-ref-21258094'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e93e521b-dcf8-4c9e-a517-ce735b97e18a">Odontogenic infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Odontogenic infection (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Acute simple gingivitis, plaque-associated: Note: </b>Reserve systemic therapy for patients with rapidly progressive disease, severe pain, or immunocompromising conditions (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Chow.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Chow.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral:</b> Immediate release: 875 mg every 12 hours <b>or</b> 500 mg every 8 hours for 5 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Chow.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Chow.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Periodontitis, severe, plaque-associated: Oral:</b> Immediate release: 875 mg every 12 hours <b>or</b> 500 mg every 8 hours for 14 days or until clinical resolution, whichever is longer; use in addition to periodontal debridement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Chow.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Chow.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Pyogenic odontogenic soft tissue infection (initial therapy for mild infection or step-down therapy after parenteral treatment):</b>
<b>Oral:</b> Immediate release: 875 mg every 12 hours <b>or </b>500 mg every 8 hours; continue until clinical resolution, typically for 7 to 14 days. Use in addition to appropriate surgical management (eg, drainage and/or extraction) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Chow.2019','lexi-content-ref-8393108','lexi-content-ref-26300919']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Chow.2019','lexi-content-ref-8393108','lexi-content-ref-26300919'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a96b8104-65d0-48ba-b460-4308464e6db6">Otitis media, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Immediate release: <b>Oral: </b>875 mg twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11806623']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11806623'])">Ref</a></span>) <b>or</b> 500 mg every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-WHO.2001']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-WHO.2001'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Extended release: <b>Oral: </b>1 or 2 g twice daily, based on weight and severity of infection; some experts prefer the extended release formulation for patients at high risk of severe infection or resistant <i>S. pneumoniae </i>(<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Limb.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Limb.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Duration: 5 to 7 days for mild to moderate infection and 10 days for severe infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Limb.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Limb.2019'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="132d091d-3c81-4ef2-aaa6-dd6482044311">Peritonsillar cellulitis or abscess</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Peritonsillar cellulitis or abscess (off-label-use): Note: </b>For step-down therapy after parenteral treatment. Limited data available; dosing based on expert opinion. <b>Oral:</b> Immediate release: 875 mg every 12 hours to complete a total of 14 days of therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Wald.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Wald.2019'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7792e77c-7758-4230-a81e-dc7dd3a6acb9">Pneumonia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumonia:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>
<i>Aspiration pneumonia (community acquired [mild])</i>:</b></p>
<p style="text-indent:-2em;margin-left:6em;">Immediate release: <b>Oral: </b>875 mg twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bartlett.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bartlett.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Extended release: <b>Oral: </b>2 g twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bartlett.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bartlett.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Duration of therapy: Generally 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bartlett.2019']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bartlett.2019'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>
<b>Community-acquired pneumonia:</b></i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note:</b> For empiric therapy in outpatients with comorbidities or oral step-down therapy following initial parenteral therapy in patients who are hospitalized (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Immediate release: <b>Oral: </b>500 mg 3 times daily <b>or</b> 875 mg twice daily as part of an appropriate combination regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Extended release: <b>Oral: </b>2 g twice daily as part of an appropriate combination regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Duration of therapy: Minimum of 5 days; patients should be clinically stable with normal vital signs before therapy is discontinued (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1437b55a-5145-4c15-bba4-c28709c37109">Rhinosinusitis, acute bacterial</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rhinosinusitis, acute bacterial:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> In uncomplicated acute bacterial rhinosinusitis, initial observation and symptom management without antibiotic therapy is appropriate in most patients. Reserve antibiotic therapy for poor follow-up or lack of improvement over the observation period (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25832968','lexi-content-ref-26785402']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25832968','lexi-content-ref-26785402'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Standard dose: <b>Oral:</b> Immediate release: 500 mg every 8 hours <b>or</b> 875 mg every 12 hours for 5 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22438350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22438350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">High dose: <b>Oral:</b> Extended release: 2 g every 12 hours for 5 to 7 days. <b>Note:</b> Recommended for patients at risk for poor outcome or pneumococcal resistance based on the following features: ≥65 years of age, recent hospitalization or antibiotic use, multiple comorbidities, high endemic resistance (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25832968','lexi-content-ref-22438350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25832968','lexi-content-ref-22438350'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8ea91cf4-641d-4163-8d29-4fbcff84d8a4">
<i>Streptococcus</i>, chronic carriage</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Streptococcus</i> (group A), chronic carriage (off-label use):</b>
<b>Oral:</b> Immediate release: 40 mg/kg/day in divided doses (eg, 875 mg every 12 hours) (maximum: 2 g/day) for 10 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22965026','lexi-content-ref-16490583']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22965026','lexi-content-ref-16490583'])">Ref</a></span>). <b>Note:</b> Most individuals with chronic carriage do not require antibiotics (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22965026']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22965026'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5ac615e6-688a-461c-8a9f-5e7703d06ac9">Urinary tract infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary tract infection (alternative agent): </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Use only when preferred first-line agents cannot be used; limited evidence suggests inferior efficacy of oral beta-lactams (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21292654']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21292654'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Cystitis, acute uncomplicated or acute simple cystitis (infection limited to the bladder without signs/symptoms of upper tract, prostate, or systemic infection)</i>
<i>:</i>
<b>Oral:</b> Immediate release: 500 mg twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15728165']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15728165'])">Ref</a></span>) for 5 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Hooton.2018a','lexi-content-ref-21292654']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Hooton.2018a','lexi-content-ref-21292654'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Urinary tract infection, complicated (including pyelonephritis)</i>
<i>: </i>
<b>Oral:</b> Immediate release: 875 mg twice daily for 10 to 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21292654','lexi-content-ref-29298155']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21292654','lexi-content-ref-29298155'])">Ref</a></span>); for patients with symptomatic improvement within the first 48 to 72 hours of therapy, some experts recommend shorter courses of 7 to 10 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Hooton.2018b','lexi-content-ref-30535100']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Hooton.2018b','lexi-content-ref-30535100'])">Ref</a></span>). <b>Note:</b> Oral beta-lactam therapy should generally follow appropriate parenteral therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Hooton.2018b','lexi-content-ref-21292654']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Hooton.2018b','lexi-content-ref-21292654'])">Ref</a></span>).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50991105"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">The renal dosing recommendations are based upon the best available evidence and clinical expertise. Senior Editorial Team: Bruce Mueller, PharmD, FCCP, FASN, FNKF; Jason A. Roberts, PhD, BPharm (Hons), B App Sc, FSHP, FISAC; Michael Heung, MD, MS.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Renally adjusted dose recommendations are based on the amoxicillin component of the amoxicillin 250 mg/clavulanate 125 mg and amoxicillin 500 mg/clavulanate 125 mg tablets. Avoid IR 875 mg tablet or ER tablets in patients with CrCl &lt;30 mL/minute.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Altered kidney function: Note:</b> Although the manufacturer's labeling for some products utilizes the term GFR to present dose adjustment cutoffs, pharmacokinetic studies utilized CrCl measurements (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-7141752','lexi-content-ref-3707111','lexi-content-ref-6600085','lexi-content-ref-4618910']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-7141752','lexi-content-ref-3707111','lexi-content-ref-6600085','lexi-content-ref-4618910'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">CrCl ≥30 mL/minute: No dosage adjustment necessary.</p>
<p style="text-indent:-2em;margin-left:6em;">CrCl 10 to &lt;30 mL/minute: 250 to 500 mg every 12 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">CrCl &lt;10 mL/minute: 250 to 500 mg every 12 to 24 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Hemodialysis, intermittent (thrice weekly):</b> Dialyzable (30% to 47% [amoxicillin component], 34% [clavulanic acid] with low-flux filters (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-3190988','lexi-content-ref-445959']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-3190988','lexi-content-ref-445959'])">Ref</a></span>)): 250 to 500 mg every 12 to 24 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28502697','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28502697','lexi-content-ref-manu.1'])">Ref</a></span>). If utilizing a 24-hour dosing interval, administer dose after dialysis or give an additional dose after dialysis on dialysis days.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Peritoneal dialysis:</b> 250 to 500 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>IV</b> [Canadian product]: <b>Note:</b> Dose based on amoxicillin component.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Altered kidney function:</b></p>
<p style="text-indent:-2em;margin-left:6em;">CrCl ≥30 mL/minute: No dosage adjustment necessary.</p>
<p style="text-indent:-2em;margin-left:6em;">CrCl 10 to 30 mL/minute: Initial: 1 g followed by 500 mg every 12 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">CrCl &lt;10 mL/minute: Initial: 1 g followed by 500 mg every 12 to 24 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Hemodialysis, intermittent (thrice weekly):</b> Dialyzable (30% to 47% [amoxicillin component] with low-flux filters (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-3190988','lexi-content-ref-445959']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-3190988','lexi-content-ref-445959'])">Ref</a></span>)): Initial: 1 g followed by 500 mg every 12 to 24 hours. If utilizing a 24-hour dosing interval, administer dose after dialysis or give an additional 500 mg dose after dialysis on dialysis days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Peritoneal dialysis:</b> Initial: 1 g followed by 500 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Expert.DOR']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Expert.DOR'])">Ref</a></span>).</p></div>
<div class="block doha drugH1Div" id="F50988406"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Oral, IV</b> [Canadian product]: There are no dosage adjustments provided in the manufacturer's labeling; use with caution. Use contraindicated in patients with a history of amoxicillin and clavulanate-associated hepatic dysfunction.</p></div>
<div class="block arsc drugH1Div" id="F54959727"><span class="drugH1">Adverse Reactions (Significant): Considerations</span>
<div class="collapsible">
<span class="collapsible-title">Antibiotic-associated (non-Clostridioides difficile) diarrhea</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">GI effects range from antibiotic-associated [non-C.diff] diarrhea (AAD), nausea, and vomiting. Most cases of AAD are mild and self-limiting (Mullish 2018). However, <i>Clostridioides difficile</i> may account for as many as &gt;20% of cases in children, adolescents, and adults (discussed separately) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003987','lexi-content-ref-29408016','lexi-content-ref-17385141']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003987','lexi-content-ref-29408016','lexi-content-ref-17385141'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism</i>: Dose- and time-related. In addition to antibiotic disruption of indigenous gut microbiota, clavulanic acid appears to stimulate small-bowel motility (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11821511','lexi-content-ref-9798020','lexi-content-ref-18811240']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11821511','lexi-content-ref-9798020','lexi-content-ref-18811240'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset</i>: Varied; mean time to onset of AAD is 3 to 18 days for adult patients and 2 to 6 days for pediatric patients. The majority of AAD cases occur during (versus after) antibiotic therapy in pediatric patients (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003987']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003987'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">• More common with amoxicillin/clavulanic acid than with amoxicillin or ampicillin alone (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11821511','lexi-content-ref-25404399','lexi-content-ref-31561959']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11821511','lexi-content-ref-25404399','lexi-content-ref-31561959'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• More frequent dosing (eg, 3 times daily versus twice daily) and higher amounts of clavulanic acid (eg, high-dose amoxicillin/clavulanate) may increase risk in pediatric patients (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-12534334','lexi-content-ref-31561959']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-12534334','lexi-content-ref-31561959'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Duration of therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891','lexi-content-ref-31118710','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891','lexi-content-ref-31118710','lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Age (pediatric patients &lt;2 years of age and older adults) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891','lexi-content-ref-31118710','lexi-content-ref-27003987','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891','lexi-content-ref-31118710','lexi-content-ref-27003987','lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Length of hospitalization or ICU stay (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891','lexi-content-ref-31118710','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891','lexi-content-ref-31118710','lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Duration of proton pump inhibitor use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Parenteral nutrition (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Combinations of antibiotics (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891','lexi-content-ref-31118710']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891','lexi-content-ref-31118710'])">Ref</a></span>)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Clostridioides difficile infection</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<i>Clostridioides difficile</i> infection (CDI) has occurred, including <b>
<i>Clostridioides difficile</i> associated diarrhea</b> and <b>
<i>Clostridioides difficile</i> colitis</b>. (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32069358','lexi-content-ref-24324224']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32069358','lexi-content-ref-24324224'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset: </i>Varied; may start on the first day of antibiotic therapy or up to 3 months postantibiotic (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22146873','lexi-content-ref-29053792']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22146873','lexi-content-ref-29053792'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors: </i></p>
<p style="text-indent:-2em;margin-left:6em;">• Antibiotic exposure (highest risk factor), especially prolonged use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32069358','lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32069358','lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Type of antibiotic (penicillin combination antibiotics, including amoxicillin and clavulanate, have been associated with increased risk) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32069358','lexi-content-ref-24324224']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32069358','lexi-content-ref-24324224'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Long durations in a hospital or other healthcare setting (recent or current) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Older adults (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Immunocompromised conditions (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• A serious underlying condition (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• GI surgery/manipulation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29462280','lexi-content-ref-27216385']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29462280','lexi-content-ref-27216385'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Antiulcer medications (eg, proton pump inhibitors and H2 blockers) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2020','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2020','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Chemotherapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.2020','lexi-content-ref-29053792','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• In pediatric patients, community-acquired CDI was associated with amoxicillin/clavulanate, cephalosporins, or clindamycin use in the prior 12 weeks, as well as non-Hispanic race, more health care visits, and prior positive <i>Clostridioides difficile</i> test in the past 6 months (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32171559']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32171559'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Drug-induced liver injury</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">Although rarely fatal, drug-induced liver injury has been reported. The most frequent presentation is <b>cholestatic hepatitis</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003146','lexi-content-ref-8651842']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003146','lexi-content-ref-8651842'])">Ref</a></span>). Most patients recover after drug discontinuation, but there are reports of death or patients who require liver transplantation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003146','lexi-content-ref-16187174']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003146','lexi-content-ref-16187174'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism</i>: Non-dose-related; primarily immunologic, mediated by T-cells (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25418487']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25418487'])">Ref</a></span>). Genetic variation at human leukocyte antigen class I &amp; II loci has been shown to be associated with amoxicillin/clavulanic acid induced liver jury (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21570397']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21570397'])">Ref</a></span>). Unknown whether the liver injury is due to amoxicillin or clavulanic acid or both (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003146']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003146'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset</i>: Variable; most cases occur within 12 weeks after initial drug exposure (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003146']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003146'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">• Older male patients, most often of Caucasian race, are at greater risk (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003146']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003146'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Serious underlying disease</p>
<p style="text-indent:-2em;margin-left:6em;">• Concomitant medications (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003146']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003146'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Repeated courses of therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-8651842']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-8651842'])">Ref</a></span>)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Hypersensitivity (immediate and delayed)</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">Immediate, including <b>urticaria</b>, <b>angioedema</b> and <b>anaphylaxis</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25913298']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25913298'])">Ref</a></span>), and delayed hypersensitivity reactions have been reported in all ages (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31924232']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31924232'])">Ref</a></span>). Delayed hypersensitivity reactions range from maculopapular <b>skin rash</b> to rare severe cutaneous adverse reactions (SCARs), including <b>acute generalized exanthematous pustulosis</b>, <b>drug reaction with eosinophilia and systemic symptoms</b>, <b>Stevens-Johnson syndrome</b>, and <b>toxic epidermal necrolysis </b>in all ages (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27005794','lexi-content-ref-31321789','lexi-content-ref-28599076','lexi-content-ref-31924232','lexi-content-ref-30298362','lexi-content-ref-29569759']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27005794','lexi-content-ref-31321789','lexi-content-ref-28599076','lexi-content-ref-31924232','lexi-content-ref-30298362','lexi-content-ref-29569759'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism</i>: Non-dose-related; immunologic. Immediate hypersensitivity reactions (eg, anaphylaxis, urticaria) are IgE-mediated. Delayed hypersensitivity reactions, including maculopapular rash and SCARs are T-cell-mediated (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30558872','lexi-content-ref-28599076']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30558872','lexi-content-ref-28599076'])">Ref</a></span>). In patients with reactions to amoxicillin/clavulanic acid, the reaction can be mediated by the amoxicillin or clavulanic acid component (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32246774','lexi-content-ref-25913298','lexi-content-ref-20434202']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32246774','lexi-content-ref-25913298','lexi-content-ref-20434202'])">Ref</a></span>), or some patients may be sensitized independently to both amoxicillin and clavulanic acid (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28342830']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28342830'])">Ref</a></span>). Approximately 30% of patients have selective reactions to clavulanic acid (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26662186']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26662186'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset</i>: Immediate hypersensitivity reactions: Rapid; generally occur within 1 hour of administration but may occur up to 6 hours after exposure (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30558872']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30558872'])">Ref</a></span>). Delayed hypersensitivity reactions: Maculopapular reactions: Intermediate; occur 7 to 10 days after initiation. Other reactions (including SCARs): Variable; occur after 7 to 14 days up to 3 months) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30558872','lexi-content-ref-26120552','lexi-content-ref-NICE.2014']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30558872','lexi-content-ref-26120552','lexi-content-ref-NICE.2014'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors:</i></p>
<p style="text-indent:-2em;margin-left:6em;">• Rash may develop in 9% to 23% of patients with Epstein-Barr virus (EBV) infection (infectious mononucleosis) who are not on antibiotics. Although previous studies indicated that concomitant administration of an aminopenicillin, specifically ampicillin or amoxicillin, may increase the risk of rash in these patients, more recent studies suggest that amoxicillin/clavulanic acid may not increase the risk of rash. In one study, 12.5% of EBV-infected patients who used amoxicillin/clavulanic acid developed a rash (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29617685']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29617685'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">• Cross-reactivity between beta-lactams (related to side chain similarity) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27016799','lexi-content-ref-29408440']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27016799','lexi-content-ref-29408440'])">Ref</a></span>). No cross-reactivity reported between clavulanic acid and penicillins, likely due to differences in chemical structures (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25913298','lexi-content-ref-26662186']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25913298','lexi-content-ref-26662186'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F134582"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Gastrointestinal: Diarrhea (3% to 34%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Candidal diaper rash (4% to 6%), diaper rash (4%), skin rash (≤3%), urticaria (≤3%)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Nausea (2% to 3%), vomiting (1% to 2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Vaginal mycosis (3%), vaginitis (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Candidiasis (1%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Abdominal distress, flatulence</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Thrombocytosis</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Headache</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Acute generalized exanthematous pustulosis (Hioki 2019), bullous dermatitis (linear IgA) (Panasiti 2009), erythema multiforme (Peng 2013), exfoliative dermatitis (Barni 2018), fixed drug eruption (Perez-Ezquerra 2010), pruritus, Stevens-Johnson syndrome (Mori 2017), Sweet syndrome (histiocytoid) (Yuksek 2022), toxic epidermal necrolysis (Rodriguez-Martin 2019)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: <i>Clostridioides difficile</i> colitis, <i>Clostridioides difficile</i>-associated diarrhea (Brown 2020; Slimings 2014), dyspepsia, enterocolitis (including drug-induced enterocolitis syndrome [DIES]) (Freundt Serpa 2020), gastritis, glossitis, hemorrhagic colitis (Youn 2018), melanoglossia, mucocutaneous candidiasis, pancreatitis (Chams 2018), staining of tooth (Garcia-Lopez 2001), stomatitis</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Crystalluria (van Noord 2012), hematuria (Asim 2021)</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Agranulocytosis (Armas Villalba 2019), anemia, eosinophilia, hemolytic anemia, immune thrombocytopenia, leukopenia, thrombocytopenia (Mansour 2014)</p>
<p style="text-indent:-2em;margin-left:4em;">Hepatic: Acute hepatic failure (Fontana 2005), cholestatic hepatitis (Chalasani 2014; deLemos 2016), hepatocellular hepatitis (Chalasani 2014; deLemos 2016), jaundice (deLemos 2016)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis (including Kounis syndrome) (Moloney 2019), angioedema (Salvo 2007), drug reaction with eosinophilia and systemic symptoms (van Kester 2018), hypersensitivity angiitis, nonimmune anaphylaxis, serum sickness-like reaction (Patterson-Fortin 2016), type IV hypersensitivity reaction (Copaescu 2020)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Agitation, anxiety, aseptic meningitis (Chandler 2019), behavioral changes (Macknin 1987), confusion, dizziness, insomnia, myoclonus (Viloria-Alebesque 2020), reversible hyperactivity</p>
<p style="text-indent:-2em;margin-left:4em;">Renal: Interstitial nephritis (including acute interstitial nephritis; can be hemorrhagic) (Asim 2021)</p></div>
<div class="block coi drugH1Div" id="F134598"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity to amoxicillin, clavulanic acid, other beta-lactam antibacterial drugs (eg, penicillins, cephalosporins), or any component of the formulation; history of cholestatic jaundice or hepatic dysfunction with amoxicillin/clavulanate potassium therapy.</p>
<p style="text-indent:-2em;margin-left:2em;">Augmentin XR: Additional contraindications: Severe renal impairment (CrCl &lt;30 mL/minute) and patients on hemodialysis.</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<i>Canadian labeling:</i> Additional contraindications (not in the US labeling): Suspected or confirmed mononucleosis.</p></div>
<div class="block war drugH1Div" id="F134579"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Clavulanic acid content: Due to differing content of clavulanic acid, not all formulations are interchangeable; use of an inappropriate product for a specific dosage could result in either diarrhea (which may be severe) or subtherapeutic clavulanic acid concentrations leading to decreased clinical efficacy.</p>
<p style="text-indent:-2em;margin-left:4em;">• Phenylalanine: Some products contain phenylalanine.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F57833968"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Diarrhea has been reported with amoxicillin and clavulanate; incidence increases with clavulanate dose. Some experts recommend not exceeding 10 mg clavulanate/kg/<b>day</b>, 5 mg clavulanate/kg/dose, or 125 mg clavulanate/<b>dose</b> (Yu 2022). In a study of patients 6 to 23 months of age with acute otitis media (n=112), patients who received amoxicillin 80 mg/kg/day and clavulanate 2.85 mg/kg/day (novel formulation not currently available) experienced less diarrhea and diaper dermatitis but similar efficacy as compared to historical controls receiving amoxicillin 90 mg/kg/day and clavulanate 6.4 mg/kg/day (Hoberman 2017). Minimum dose requirement for optimal inhibition of beta-lactamases and pharmacodynamic predictor of efficacy for clavulanate have not been defined (Crass 2019). Dosing per manufacturer's labeling for patients &lt;40 kg results in a clavulanate dose of 3.6 to 10 mg/kg/day (4:1 ratio formulations: 5 to 10 mg/kg/day; 7:1 ratio formulations: 3.6 to 6.4 mg/kg/day; 14:1 formulation: 6.4 mg/kg/day).</p></div>
<div class="block dosfc drugH1Div" id="F54526180"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">IV [Canadian product]: 500 mg, 1 g, and 2 g vials contain 31.4 mg (1.4 mmoL), 62.9 mg (2.7 mmoL), and 125.9 mg (5.5 mmoL) of sodium and 19.6 (0.5 mmoL), 39.3 mg (1 mmoL) and 39.3 mg (1 mmoL) of potassium, respectively.</p></div>
<div class="block foc drugH1Div" id="F54994785"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Reconstituted, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Augmentin: Amoxicillin 250 mg and clavulanate potassium 62.5 mg per 5 mL (75 mL [DSC], 100 mL [DSC], 150 mL [DSC]); Amoxicillin 125 mg and clavulanate potassium 31.25 mg per 5 mL (75 mL [DSC], 100 mL [DSC], 150 mL [DSC]) [contains saccharin sodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Augmentin: Amoxicillin 125 mg and clavulanate potassium 31.25 mg per 5 mL (100 mL, 150 mL) [contains saccharin sodium; banana flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Augmentin ES-600: Amoxicillin 600 mg and clavulanate potassium 42.9 mg per 5 mL (75 mL [DSC], 125 mL [DSC], 200 mL [DSC]) [contains aspartame; strawberry cream flavor]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 200 mg and clavulanate potassium 28.5 mg per 5 mL (50 mL, 75 mL, 100 mL); Amoxicillin 250 mg and clavulanate potassium 62.5 mg per 5 mL (75 mL, 100 mL, 150 mL); Amoxicillin 400 mg and clavulanate potassium 57 mg per 5 mL (50 mL, 75 mL, 100 mL); Amoxicillin 600 mg and clavulanate potassium 42.9 mg per 5 mL (75 mL, 125 mL, 200 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Reconstituted, Oral [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Augmentin ES-600: Amoxicillin 600 mg and clavulanate potassium 42.9 mg per 5 mL (200 mL) [contains aspartame; strawberry cream flavor]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Augmentin: Amoxicillin 500 mg and clavulanate potassium 125 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 250 mg and clavulanate potassium 125 mg, Amoxicillin 500 mg and clavulanate potassium 125 mg, Amoxicillin 875 mg and clavulanate potassium 125 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Chewable, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 200 mg and clavulanate potassium 28.5 mg, Amoxicillin 400 mg and clavulanate potassium 57 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Extended Release 12 Hour, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 1000 mg and clavulanate potassium 62.5 mg</p></div>
<div class="block geq drugH1Div" id="F54994784"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F134601"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Chewable</b> (Amoxicillin-Pot Clavulanate Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">200-28.5 mg (per each): $3.08</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">400-57 mg (per each): $5.88</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension (reconstituted)</b> (Amoxicillin-Pot Clavulanate Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">200-28.5 mg/5 mL (per mL): $0.36 - $0.39</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">250-62.5 mg/5 mL (per mL): $0.86 - $0.88</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">400-57 mg/5 mL (per mL): $0.69 - $0.74</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">600-42.9 mg/5 mL (per mL): $0.49 - $0.68</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension (reconstituted)</b> (Augmentin ES-600 Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">600-42.9 mg/5 mL (per mL): $5.49</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension (reconstituted)</b> (Augmentin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">125-31.25 mg/5 mL (per mL): $7.21</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablet, 12-hour</b> (Amoxicillin-Pot Clavulanate ER Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1000-62.5 mg (per each): $7.67</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Amoxicillin-Pot Clavulanate Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">250-125 mg (per each): $5.92</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500-125 mg (per each): $3.78 - $6.00</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">875-125 mg (per each): $5.05 - $9.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Augmentin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500-125 mg (per each): $11.57</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F54994787"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution Reconstituted, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 1000 mg and clavulanate potassium 200 mg (1 ea); Amoxicillin 2000 mg and clavulanate potassium 200 mg (1 ea); Amoxicillin 500 mg and clavulanate potassium 100 mg (1 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Reconstituted, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clavulin: Amoxicillin 400 mg and clavulanate potassium 57 mg per 5 mL (70 mL); Amoxicillin 200 mg and clavulanate potassium 28.5 mg per 5 mL (70 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clavulin-125F: Amoxicillin 125 mg and clavulanate potassium 31.25 mg per 5 mL (100 mL, 150 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clavulin-250F: Amoxicillin 250 mg and clavulanate potassium 62.5 mg per 5 mL (100 mL, 150 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 125 mg and clavulanate potassium 31.25 mg per 5 mL ([DSC]); Amoxicillin 400 mg and clavulanate potassium 57 mg per 5 mL (70 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clavulin: Amoxicillin 875 mg and clavulanate potassium 125 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clavulin-500F: Amoxicillin 500 mg and clavulanate potassium 125 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Amoxicillin 250 mg and clavulanate potassium 125 mg, Amoxicillin 500 mg and clavulanate potassium 125 mg, Amoxicillin 875 mg and clavulanate potassium 125 mg</p></div>
<div class="block admp drugH1Div" id="F52612230"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Immediate-release formulations may be given without regard to meals; however, administer at the start of a meal to decrease the frequency or severity of GI side effects and improve absorption; administer extended-release tablet at the start of a meal. Shake suspension well before use.</p>
<p style="text-indent:-2em;margin-left:2em;">IV [Canadian product]: Administer as an infusion over 30 to 40 minutes. In infants ≥3 months, children, and adolescents, 5:1 formulations (500/100 mg and 1,000/200 mg) may also be administered by slow IV injection over 3 to 4 minutes.</p></div>
<div class="block adm drugH1Div" id="F134595"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b> Administer around-the-clock to promote less variation in peak and trough serum levels. Administer with food to increase absorption and decrease stomach upset; shake suspension well before use. ER tablets should be administered with food.</p>
<p style="text-indent:-2em;margin-left:4em;">Bariatric surgery: Tablet, extended release: Some institutions may have specific protocols that conflict with these recommendations; refer to institutional protocols as appropriate. Do not cut, crush, or chew. Switch to IR formulation.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>IV</b> [Canadian product]: Administer by slow IV injection over 3 to 4 minutes (500 mg or 1 g dose <b>only</b>) or as an infusion over 30 to 40 minutes.</p></div>
<div class="block sts drugH1Div" id="F134608"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Powder for oral suspension: Store dry powder at or below 25°C (77°F). Reconstituted oral suspension should be kept in refrigerator. Discard unused suspension after 10 days (consult manufacturer's labeling for specific recommendations). Unit-dose antibiotic oral syringes are stable under refrigeration for 24 hours (Tu 1988).</p>
<p style="text-indent:-2em;margin-left:4em;">Tablet: Store at or below 25°C (77°F). Dispense in original container.</p>
<p style="text-indent:-2em;margin-left:2em;">IV [Canadian product]: Store intact vials at 15°C to 30°C (59°F to 86°F). Store reconstituted solution at 15°C to 30°C (59°F to 86°F) for up to 15 minutes. Solutions diluted for infusion should be used within 1 hour if stored at 25°C (77°F) or within 4 hours if stored at 4°C (30°F); recommendations may vary based on solution used for dilution, refer to manufacturer’s labeling for detailed information.</p></div>
<div class="block usep drugH1Div" id="F53565402"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of lower respiratory tract infections, acute otitis media, sinusitis, skin and soft tissue infections, and urinary tract infections caused by susceptible bacteria (FDA approved in all ages).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note:</b> Approved indications and ages may vary by product; consult product-specific labeling for details.</p>
<p style="text-indent:-2em;margin-left:2em;">Powder for oral suspension:</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 125 mg/clavulanate 31.25 mg/5 mL (4:1): FDA approved in all ages.</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 200 mg/clavulanate 28.5 mg/5 mL (7:1): FDA approved in ages ≥3 months and adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 250 mg/clavulanate 62.5 mg/5 mL (4:1): FDA approved in ages ≥3 months and adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 400 mg/clavulanate 57 mg/5 mL (7:1): FDA approved in ages ≥3 months and adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 600 mg/clavulanate 42.9 mg/5 mL (14:1): FDA approved in pediatric patients ≥3 months and &lt;40 kg.</p>
<p style="text-indent:-2em;margin-left:2em;">Tablet, chewable:</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 200 mg/clavulanate 28.5 mg (7:1): FDA approved in pediatric patients (age not specified).</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 400 mg/clavulanate 57 mg (7:1): FDA approved in pediatric patients (age not specified).</p>
<p style="text-indent:-2em;margin-left:2em;">Tablet, oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 250 mg/clavulanate 125 mg (2:1): FDA approved in pediatric patients ≥40 kg and adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 500 mg/clavulanate 125 mg (4:1): FDA approved in pediatric patients ≥40 kg and adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin 875 mg/clavulanate 125 mg (7:1): FDA approved in pediatric patients ≥40 kg and adults.</p>
<p style="text-indent:-2em;margin-left:2em;">Extended-release tablet: Amoxicillin 1,000 mg/clavulanate 62.5 mg (16:1): FDA approved in pediatric patients ≥40 kg and adults.</p></div>
<div class="block mst drugH1Div" id="F134644"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Augmentin may be confused with amoxicillin, Azulfidine</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13298742"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">Refer to individual components.</p></div>
<div class="block dri drugH1Div" id="F134584"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Acemetacin: May increase the serum concentration of Penicillins.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Allopurinol: May enhance the potential for allergic or hypersensitivity reactions to Amoxicillin.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Aminoglycosides: Penicillins may decrease the serum concentration of Aminoglycosides. Primarily associated with extended spectrum penicillins, and patients with renal dysfunction. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Bacillus clausii: Antibiotics may diminish the therapeutic effect of Bacillus clausii.  Management: Bacillus clausii should be taken in between antibiotic doses during concomitant therapy.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine.  Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Dichlorphenamide: Penicillins may enhance the hypokalemic effect of Dichlorphenamide. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Fecal Microbiota (Live) (Oral): May diminish the therapeutic effect of Antibiotics.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Fecal Microbiota (Live) (Rectal): Antibiotics may diminish the therapeutic effect of Fecal Microbiota (Live) (Rectal). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Immune Checkpoint Inhibitors (Anti-PD-1, -PD-L1, and -CTLA4 Therapies): Antibiotics may diminish the therapeutic effect of Immune Checkpoint Inhibitors (Anti-PD-1, -PD-L1, and -CTLA4 Therapies). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Khat: May decrease the serum concentration of Amoxicillin. Management: Consider administering amoxicillin before, or 2 hours after, khat chewing to avoid reductions in amoxicillin bioavailability.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methotrexate: Penicillins may increase the serum concentration of Methotrexate. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Mycophenolate: Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Probenecid: May increase the serum concentration of Betalactamase Inhibitors. Management: Coadministration of probenecid with amoxicillin/clavulanate is not recommended per official package labeling.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sodium Benzoate: Penicillins may diminish the therapeutic effect of Sodium Benzoate. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tetracyclines: May diminish the therapeutic effect of Penicillins.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Avoid use of live attenuated typhoid vaccine (Ty21a)  in patients being treated with systemic antibacterial agents. Postpone vaccination until 3 days after cessation of antibiotics and avoid starting antibiotics within 3 days of last vaccine dose.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Vitamin K Antagonists (eg, warfarin): Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists. <i> Risk C: Monitor therapy</i></p></div>
<div class="block dic drugH1Div" id="F134604"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">May be taken with meals or on an empty stomach; take with meals to increase absorption and decrease GI upset; may mix with milk, formula, or juice. Extended release tablets should be taken with food. Some products may contain sodium. Some products contain phenylalanine. All dosage forms contain potassium.</p></div>
<div class="block pri drugH1Div" id="F134602"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Both amoxicillin and clavulanic acid cross the placenta (Muller 2009; Weber 1984). An increased risk of necrotizing enterocolitis in neonates or bowel disorders in children may be associated with amoxicillin/clavulanate when exposure occurs near delivery (Kenyon 2001).</p>
<p style="text-indent:0em;margin-top:2em;">Oral ampicillin-class antibiotics are poorly absorbed during labor. Clavulanate does not appear to influence maternal amoxicillin pharmacokinetics following IV administration of amoxicillin/clavulanate prior to delivery (Muller 2009).</p>
<p style="text-indent:0em;margin-top:2em;">As a class, penicillin antibiotics are widely used in pregnant women. Based on available data, penicillin antibiotics are generally considered compatible for use during pregnancy (Ailes 2016; Bookstaver 2015; Crider 2009; Damkier 2019; Lamont 2014; Muanda 2017a; Muanda 2017b).</p>
<p style="text-indent:0em;margin-top:2em;">Untreated urinary tract infections (UTI) during pregnancy are associated with an increased risk of developing pyelonephritis, low birth weight, and preterm labor. Amoxicillin/clavulanate may be an option for the treatment of UTI during pregnancy (Betschart 2020; de Rossi 2020; IDSA [Nicolle 2019]; Usta 2011).</p>
<p style="text-indent:0em;margin-top:2em;">Antibiotics are used in the management of preterm prelabor rupture of membranes (PROM) to prolong pregnancy and reduce the risk of infection. However, due to the possible increased risk of necrotizing enterocolitis, amoxicillin/clavulanate is not recommended for this indication (ACOG 217 2020).</p>
<p style="text-indent:0em;margin-top:2em;">Amoxicillin/clavulanate is considered compatible for the of treatment airway diseases in pregnant women. Use should be avoided in women at risk for preterm delivery (due to association with necrotizing enterocolitis) (ERS/TSANZ [Middleton 2020]).</p>
<p style="text-indent:0em;margin-top:2em;">The routine use of antibiotics prior to an operative vaginal delivery (vacuum or forceps delivery) is not currently recommended. However, amoxicillin/clavulanate IV administered after an operative vaginal delivery may decrease the risk of a maternal infection occurring within 6 weeks postpartum. A single dose may be appropriate in specific cases (Knight 2019; Liabsuetrakul 2020).</p></div>
<div class="block mopp drugH1Div" id="F53565401"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">With prolonged therapy, monitor renal, hepatic, and hematologic function; monitor for signs of hypersensitivity, including anaphylaxis.</p></div>
<div class="block pha drugH1Div" id="F134578"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Clavulanic acid binds and inhibits beta-lactamases that inactivate amoxicillin resulting in amoxicillin having an expanded spectrum of activity. Amoxicillin inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.</p></div>
<div class="block phk drugH1Div" id="F134597"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">Amoxicillin pharmacokinetics are not affected by clavulanic acid.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Amoxicillin:</b> See individual Amoxicillin monograph.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Clavulanic acid:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Distribution:</p>
<p style="text-indent:-2em;margin-left:6em;">V<sub>d</sub>: Children ≥2 years and Adolescents ≤14 years: 0.368 ± 0.014 L/kg (Schaad 1983).</p>
<p style="text-indent:-2em;margin-left:4em;">Protein binding: ~25%.</p>
<p style="text-indent:-2em;margin-left:4em;">Half-life elimination:</p>
<p style="text-indent:-2em;margin-left:6em;">Oral:</p>
<p style="text-indent:-2em;margin-left:8em;">Infants ≥8 months and Children &lt;12 years: 1.1 ± 0.3 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Adults: 1 hour.</p>
<p style="text-indent:-2em;margin-left:6em;">IV:</p>
<p style="text-indent:-2em;margin-left:8em;">Children ≥2 years and Adolescents ≤14 years: 0.81 ± 0.04 hours (Schaad 1983).</p>
<p style="text-indent:-2em;margin-left:4em;">Time to peak: Oral:</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥8 months and Children &lt;12 years: Median: 1.1 hours; range: 1 to 4 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Adults: 1.5 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">Excretion: Urine (25% to 40% as unchanged drug).</p></div>
<div class="block phksp drugH1Div" id="F55992802"><span class="drugH1">Pharmacokinetics: Additional Considerations (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Anti-infective considerations:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Parameters associated with efficacy</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">Amoxicillin: Refer to Amoxicillin monograph.</p>
<p style="text-indent:-2em;margin-left:6em;">Clavulanate (in combination with amoxicillin): Not defined.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Expected drug exposure in normal renal function:</i></p>
<p style="text-indent:-2em;margin-left:6em;">Pediatric patients, C<sub>max</sub> (peak):</p>
<p style="text-indent:-2em;margin-left:8em;">Oral suspension (4:1 ratio); single dose:</p>
<p style="text-indent:-2em;margin-left:10em;">Children 2 to 5 years of age: Amoxicillin 125 mg/clavulanate 31.25 mg per 5 mL: Mean dose amoxicillin 9.11 ± 1.83 mg/kg: Amoxicillin 3.45 ± 1.14 mg/L; clavulanate: 1.18 ± 0.63 mg/L (van Niekerk 1985).</p>
<p style="text-indent:-2em;margin-left:10em;">Children 6 to 10 years of age: Amoxicillin 250 mg/clavulanate 62.5 mg per 5 mL: Mean dose amoxicillin 12.35 ± 3.11 mg/kg: Amoxicillin: 4 ± 1.65 mg/L; clavulanate: 1.31 ± 0.79 mg/L (van Niekerk 1985).</p>
<p style="text-indent:-2em;margin-left:8em;">Oral suspension (14:1 ratio), amoxicillin 600 mg/clavulanate 42.9 mg per 5 mL; steady state:</p>
<p style="text-indent:-2em;margin-left:10em;">Infants ≥8 months of age and children ≤11 years of age: Amoxicillin 45 mg/kg/dose every 12 hours: Amoxicillin: 15.7 ± 7.7 mg/L; clavulanate: 1.7 ± 0.9 mg/L.</p>
<p style="text-indent:-2em;margin-left:8em;">Oral tablet, extended release; steady state:</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥7 years of age and adolescents ≤15 years of age (weighing ≥40 kg): Amoxicillin 2,000 mg/clavulanate 125 mg every 12 hours: Amoxicillin: 11 ± 3.34 mg/L; clavulanate: 1.17 ± 0.67 mg/L.</p>
<p style="text-indent:-2em;margin-left:8em;">IV (5:1 ratio) [Canadian product]; single dose, 2-minute infusion:</p>
<p style="text-indent:-2em;margin-left:10em;">Children ≥2 years of age and adolescents ≤14 years of age: Amoxicillin 25 mg/kg/dose: Amoxicillin: 89.4 mg/L; clavulanate: 19.5 mg/L (Schaad 1983).</p>
<p style="text-indent:-2em;margin-left:6em;">Adults, C<sub>max</sub> (peak):</p>
<p style="text-indent:-2em;margin-left:8em;">Oral tablet; steady state:</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 250 mg/clavulanate 125 mg every 8 hours: Amoxicillin: 3.3 ± 1.12 mg/L; clavulanate: 1.5 ± 0.7 mg/L.</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 500 mg/clavulanate 125 mg every 12 hours: Amoxicillin: 6.5 ± 1.41 mg/L; clavulanate: 1.8 ± 0.61 mg/L.</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 500 mg/clavulanate 125 mg every 8 hours: Amoxicillin: 7.2 ± 2.26 mg/L; clavulanate: 2.4 ± 0.83 mg/L.</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 875 mg/clavulanate 125 mg every 12 hours: Amoxicillin: 11.6 ± 2.78 mg/L; clavulanate: 2.2 ± 0.99 mg/L.</p>
<p style="text-indent:-2em;margin-left:8em;">Oral tablet, chewable; single dose:</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 250 mg/clavulanate 62.5 mg: Amoxicillin: 6.9 mg/L; clavulanate: 1.6 mg/L.</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 400 mg/clavulanate 57 mg: Amoxicillin: 6.67 ± 1.37 mg/L; clavulanate: 1.03 ± 0.33 mg/L.</p>
<p style="text-indent:-2em;margin-left:8em;">Oral tablet, extended release; single dose:</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 2 g/clavulanate 125 mg: Amoxicillin: 17 ± 4 mg/L; clavulanate: 2.05 ± 0.8 mg/L.</p>
<p style="text-indent:-2em;margin-left:8em;">IV [Canadian product]; single dose:</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 500 mg/clavulanate 100 mg, bolus: Amoxicillin: 32.2 mg/L; clavulanate: 10.5 mg/L.</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 1 g/clavulanate 200 mg, bolus: Amoxicillin: 105.4 mg/L; clavulanate: 28.5 mg/L.</p>
<p style="text-indent:-2em;margin-left:10em;">Amoxicillin 2 g/clavulanate 200 mg, 30-minute infusion: Amoxicillin: 108 mg/L; clavulanate: 13.9 mg/L.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Postantibiotic effect</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>H. influenzae:</i> 0 to &lt;2 hours; <i>S. pneumoniae:</i> 0 to &lt;3 hours; <i>Streptococcus pyogenes</i>: 0 to 3.9 hours; methicillin-susceptible <i>S. aureus</i>: 0 to 2.55 hours; Enterobacterales: 0 to &lt;1 hour (Dubois 2000; Neuhauser 2001; Thorburn 1996).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F2869364"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Amoxidin Plus | Augmatic | Augmentin | Clamox | Clavam | Clavodar | Curam | Dioclav | Enhancin | Gloclav | Julmentin | Julmentin 2x | Klavox | Medaclav | Megamox | Moxclav | Neoclav</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Aclav | Amoclav duo | Amoclav se | Amoxi Plus | Amoxicilina-clavulanico | Amoxifarma duo | Amoxigrand compuesto | Amoxitenk plus | Bi moxal | Bi moxal duo | Bioclavid | Bioxilina plus | Bioxilina Plus Duo | Clamoxol Duo | Clavulox | Clavulox Duo | Cloximar duo | Dibional | Fabamox duo | Fullcilina plus | Grinsil clavulanico | Klonalmox | Nobactam clavulanico | Nobactam clavulanico 2 | Omnigal | Omnigal s | Optamox | Plenobiotic duo | Tibimox clavulanico | Tibimox clavulanico duo | Ultrabiotic | Ultrabiotic Duo</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Amoclanhexal | Amoxicil/clavulansaeure krka | Amoxicillin/clavulansaeure a-med | Amoxicillin/clavulansaeure actavis | Amoxicillin/Clavulansaeure AptaPharma | Amoxiclavulan 1a pharma | Amoxicomp | Amoxiplus | Amoxistad plus | Augmentin | Augmentin Duo | Clavamox | Clavamox duo | Curam | Xiclav</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Alphaclav duo | Alphaclav duo forte | AMCLAVOX DUO | Amclavox Duo forte | Amoxicillin clavulanic acid | Amoxiclav juno | Amoxycillin/Clavulanic Acid Generic Health | Amoxyclav rbx | Apo Amoxi Clav | Apo amoxycillin and Clavulanic Acid | Apx amoxicillin/clavulanic acid | Augmentin | Augmentin Duo | Augmentin duo forte | Ausclav | Clamohexal | Clamohexal duo | Clamoxyl | Clavulin | Clavulin duo | Clavycillin | Cm amoxycil clavul | Curam | Curam duo | Ga amclav | Genrx amoxy clavul | Moxiclav duo | Pharmacor amoxyclav | Tw amoxycil clavul</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Amoclav | Amoksiklav | Augment | Augmentin | Avloclav | Clamox | Demoxiclave forte | Demoxil Plus | Fimoxyclav | Moxaclav | Tyclav | Ultraclav</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Amoclane eg | Amoclane eurogenerics | Amoxicillin/clavulanic acid ab | Amoxiclav | Amoxiclav Mylan | Amoxiclav Sandoz | Amoxiclav Teva | Augmentin | Bioclavid | Clavucid | Clavulics | Co amoxi | Docamoclaf</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Alvonal | Augmacillin | Augmentin | Bactoclav | Beclav | Clavam | Clavicin | Clavicin xr | Clavuject | Clavumoccid | Cledomox | Coamox | Curam | Enhancin | Fleming | Imuclav | Klacin | Synclav | Umeclav | Xeclav | Zamox</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Almexid | Alvoclav | Amoksiklav | Amoksiklav es | Amoxigamma | Amoxigard | Augmentin | Betaclava | Betaklav | Climox | Curam | Enhancin | Medoclav | Medoclav bis | Medoclav forte | Moxiclav | Neoamoclav | Penlac</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Aclaf | Amoxicilina + clavul potassio | Amoxicilina + clavulanato de potassio | Amoxicilina + clavulanato potassico | Amoxicilina clavulanato de potassio | Amplamox AC | Atak clav | Betaclav bd | Clavicin | Clavoxil | Clavulin | Clavulin bd | Clavulin es | Clavutrex | Claxam | Doclaxin | Emyclam | Lanico | Novamox | Policlavumoxil | Policlavumoxil bd | Sigma clav bd | Sinot Clav | Uciclav</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Amicosol | Augmentin | Augmentin Duo | Aziclav | Aziclav duo | Clavamox | Clavu-basan | Co amoxi | Co amoxi mepha | Co Amoxicillin | Co amoxicillin devatis | Co amoxicillin spirig hc | Co amoxicillin zentiva</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Aclav | Amfocin | Amoclan | Amoclan forte | Amoxiclav denk | Augmentin | Beclav | Biotic plus enfant | Clavam | Clavicin xr | Clavoxi care | Clavu nova | Clavuxin | Clavuxin enfant | Clavuxin nourrisson | Claxi | Cledomox | Co amoxiclav sp | Curam | Imuclav | Imuclav duo | Imuclav ultra | Klamoks | Maxiclav | Mediclav | Novaclav | Saphir | Soclav | Theoclav | Traclav | Umeclav | Vaamox | Zamox | Zanitin duo</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Ambilan | Ambilan bid | Amolex | Amolex duo | Amoxiclav | Augmentin | Augmentin BID | Bioclavid | Clavam duo | Clavinex | Clavinex duo | Clavoxilina bid | Clavulin | Maximox | Moxivulan | Vulamox | Zolimax duo</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Alker | Amoclar | Amoksiklav | Amoxicillin and Clavula. Potassium | Amoxicillin and clavulanate potassiu. | Amoxicillin and clavulanate potassium | Amoxicillin and clavulanate potassium (14:1) | Amoxicillin and clavulanate potassium chewable tablets (8:1) | Amoxicillin and clavulanate potassium dispersible tablets (4:1) | Amoxicillin and clavulanate potassium dispersible tablets(14:1) | Amoxicillin sodium and clavulanate potassium | Amoxycillin | An mie jun | An qi | An sa lin | Anke | Ao ge men ting | Ao xian | Augmentin | Bang lin | Bi qi er | Cheng xi kai | Chong mei | Co-amoxiclav | Curam | Feng ke lin | Fu rui bo kang | Hai ke la | Hyphidga | Jian ao | Jida a bang | Jin li shu | Jun er qing | Li ding sha | Nuo ke | Qiang li a mo xian | Qing ke lin | Rui si | Seger | Sheng ai | Shi di xin | Shu xian lin | Wei Li Jia | You lin jia | You neng | Yuan xin | Zhong nuo ke lin | Zu neng</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Acix | Amoxclaver | AMOXICILINA + ACIDO CLAVULANICO | Amoxicilina + clavulanato de potasio | Amoxicilina acido clavulanico vitalis | Amoxicillina/Acido clavulanico | Amoxicladelt | Amoxiclin | Amoxiclin duo | Amoxiclin duo ninos | Amoxidal plus | Atak clav | Biomicilina | Clamicil bid | Clavulin | Curam | Curam junior | Ipiclav | Koact | Nirmox cl | Obnarin | Sumivulin | Vulamox</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Afreloxa | Amoksiklav | Amoxicillin/clavulanic acid aurovitas | Amoxicillin/clavulanic acid dr.max | Amoxicillin/clavulanic acid mylan | Amoxicillin/clavulanic aptapharma | Amoxicillin/clavulanic olikla | Augmentin | Betaklav | Curam | Enhancin | Medoclav | Megamox | Penlac</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Amoclanhexal | Amoclav | Amoxclav | Amoxclav hexal | Amoxi clavulan Al | Amoxi clavulan puren | Amoxi saar plus | Amoxi-clavulan | Amoxicillin comp | Amoxicillin comp. | Amoxicillin plus | Amoxicillin Ratiopharm comp | Amoxicillin/clavulanic acid micro labs | Amoxicillin/clavulansaeure al | Amoxicillin/clavulansaeure devatis | Amoxicillin/Clavulansaeure Heumann | Amoxicillin/Clavulansaeure Micro Labs | Amoxicillin/clavulansaeure zentiva | Amoxicillin/Clavulansaure AAA Pharma | Amoxiclav | Amoxiclav alkem | Amoxiclav aristo | Amoxiclav ct | Amoxiclav Fair Med | Amoxiclav hikma | Amoxiclav ibisqus | Amoxidura plus | Amoxillat clav | Amoxiplus comp | Augmentan | Augmentin | Augmentine | Bioclavid | Co amoxiclav | Infectosupramox</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Acimox ac | Amator 1000 | AMOXICILINA + ACIDO CLAVULANICO | Amoxicilina acido clavulanico calox | Amoxicilina y clavulanato potasico | Apo Amoxi Clav | Augmentin | Bactoclav | Clamicil | Clavam | Clavinex duo | Clavoxilina bid | Clavucyd bid | Clavulin | Cluvoxin | Curam | Duo amox | Enhancin | Fulgram | Kanex | Laprimox clav | Mediclav | Mopen plus | Moxil duo aglf | Noprilam | Rovulanato A | Suclav | Sumox ac</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Amocla | Amolex Bid | Amolex Uf | Amoxicilina + ac.clavulanico | Amoxicilina + acido clavulanico | Amoxidin cl | Augmentin | Augmentin bd | Augmentin es | Clavinex | Clavinex duo | Clavoxine | Clavucid | Clavunix | Clavurol | Clavutam | Curam | Edvabac | Edvabac acino | Enhancin | Fabamox duo | Oxialvulam | Reproxil | Sinergia | Vulamox</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Amclav | Amoclav 500 plus | Amoksiklav | Amoksiklav 2x | Amoxicillin/clavulanic acid | Amoxicillin/clavulanic acid actavis | Amoxiklav | Augmentin | Betaklav | Curam | Medoclav | Moxiclav | Moxiline</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Amoclawin | Augmacillin | Augmentin | Averobios | Bioclavox | Clavimox | Clavocillin | Clavosigma | Clavucin | Curam | Curiclav | Deltaclav | E moxclav | Gardinova | Hibiotic | Hibiotic n | Julmentin | Klavox | Maclavex | Magna biotic | Megamox | New Clav</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilina + Acido Clavula. Sandoz | Amoxicilina + Acido Clavulanico Alter | Amoxicilina + Acido Clavulanico Combino Pharm | Amoxicilina + Acido Clavulanico Genericos Juv | Amoxicilina + Acido Clavulanico Mundogen | Amoxicilina + Acido Clavulanico Normon | Amoxicilina /Acido clavulanico Mundogen | Amoxicilina /acido clavulanico pensa | Amoxicilina acido clavulanico sala | Amoxicilina clav | Amoxicilina+Acido Clavul.Ratiopharm | Amoxicilina/acido clavulanico almus | Amoxicilina/Acido clavulanico Alter | Amoxicilina/acido clavulanico ardineclav | Amoxicilina/acido clavulanico aurobindo | Amoxicilina/Acido clavulanico Cinfa | Amoxicilina/acido clavulanico Combix | Amoxicilina/acido clavulanico dermogen | Amoxicilina/Acido Clavulanico Frous | Amoxicilina/Acido clavulanico Generis | Amoxicilina/Acido clavulanico IPS | Amoxicilina/acido clavulanico kern pharma | Amoxicilina/acido clavulanico mundogen | Amoxicilina/acido clavulanico pensa | Amoxicilina/acido clavulanico sandoz | Amoxicilina/acido clavulanico tad | Amoxicilina/acido clavulanico tarbis | Amoxicilina/Acido clavulanico UR | Amoxicillin/clavulanic acid | Amoxicillin/clavulanic acid tecnigen | Amoxicillina/Clavulanico Normon | Amoxilina/Acido Clavulanico Mayne | Amoxyplus | Ardineclav | Augmentine | Clavucid | Clavumox | Duonasa | Eupeclanic | Kelsopen | Medoclav</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Acinet | Amoxicillin + clavulanic acid | Amoxicillin and clavulanate potassium | Amoxicillin and clavulanate potassium ER | Amoxicillin and potassium clavulanate | Amoxicillin sodium and clavulanate potassium | Amoxiclav denk | Augmentin | Augmentin es | Bactoclav | Clavamyn | Clavomid | Co-amoxiclav | E moxclav | Enhancin | Indclav | Injmentin | Julmentin | Julmentin 2x | Klamoks bid | Magna biotic | Medoclav | Moxipil cv | Myclav | Neoclav | Syntoclav | Syntoclav forte</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Amorion comp | Amoxicillin/clavulanic acid aurobindo | Amoxin comp | Augmentin | Betaklav | Bioclavid | Clapharin comp | Clavurion | Clavuxal | Spektramox</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilline/Acide Clavulaniq. Arrow | Amoxicilline/Acide Clavulaniq. G Gam | Amoxicilline/Acide Clavulaniq. Sandoz | Amoxicilline/Acide Clavulaniq. Teva | Amoxicilline/Acide Clavulanique | Amoxicilline/acide clavulanique alter | Amoxicilline/Acide Clavulanique Biogaran | Amoxicilline/Acide Clavulanique EG | Amoxicilline/Acide Clavulanique Merck | Amoxicilline/acide clavulanique Panpharma | Amoxicilline/Acide Clavulanique Qualimed | Amoxicilline/Acide Clavulanique Ranbaxy | Amoxicilline/Acide Clavulanique RPG | Amoxicilline/acide clavulanique sandoz | Amoxicilline/acide clavulanique Zydus | Augmentin | Ciblor | Levmentin</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Augmentin | Co amoxiclav | Co amoxiclav arrow | Co amoxiclav cox | Co-amoxiclav | Ranclav</span>;</li>
<li>
<span class="countryCode">(GH)</span> <span class="country">Ghana</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Bimox | Clavu nova | Exoclav | Ipiclav 625 | Lyclav | Rox clav</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Accordia | Amoxicillin clavulanic acid kabi | Augmentin | Bioclavid | Co Amoxiclav/Mylan | Frolicin | Fugentin | Moxiclav | Taromentin</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Augmentin | Clamovid | Clanoxy | Clavomid | Cledomox | Co amoxiclav | Co-amoxiclave | Curam | Fleming | Lidingsha | Moxiclav | Quali mentin</span>;</li>
<li>
<span class="countryCode">(HN)</span> <span class="country">Honduras</span><span class="countrySeparator">: </span><span class="drugName">Etimox duo</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav bid | Augmentin | Betaklav | Clavius | Klavax bid | Klavobel | Klavobel BID | Klavocin | Klavocin bid | KlavoPhar | Medoclav</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Aksolin | Aktil | Almowill duo | Amoclan | Amoksiklav | Amoxicillin/klavulansav aptapharma | Amoxicillin/klavulansav aurobindo | Amoxicillin/Klavulansav Mylan | Amoxilan duo | Amoxiplus | Augmentin | Augmentin biogal | Axocil duo | Betaklav | Clavumox | Curam | Enhancin | Oxamoran | Xivulan | Xylenn</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Aclam | Amocomb | Ancla | Augmentin | Auspilic | Bellamox | Betaclav | Biditin | Capsinat | Clabat | Clacomb | Clamixin | Clamobit | Claneksi | Clavamox | Claxy | Co amoxiclav | Co-amoxiclav | Co-amoxiclave | Comsikla | Danoclav | Daxet | Dexyclav | Duazat | Erabam | Hexaclav | Ikamoxyl Plus | Improvox | Inciclav | Lansiclav | Miraclav | Nufaclav | Nuvoclav | Palentin | Prafamoc | Protamox | Surpas | Syneclav | Viaclav | Viaclav Vial | Vibranat | Vulamox | Xiclav | Zumafen</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Amoclav | AMOXICILIN/CLAVULANIC ACID KRKA | Augmentin | Augmentin Duo | Augmentin-duo | Bellmentin | Clavamel | Co amoxiclav | Co amoxiclav bluefish | Co amoxiclav sugar free | Co amoxiclav teva | Germentin | Pinaclav</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Amoxiclav Teva | Augmentin | Clavamox | Claventin</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Ab cv | Abclox CV | Ac 2 | Aceclave | Aclav | Actis | Acuclav | Adclav | Admoxy cv | Admoxy duo | Adpax | Advent | Aequimentin | Allmox-c | Almox cv | Amclaid | Amclocent | Amclue | Amgat | Amkev | Amoclave | Amoclax | Amokav | Amolin cv | Amonic | Amotex ag | Amotid clav | Amoxicillin and clavulanate potassium | Amoxidol | Amoxise cv | Amoxyclav | Amoxyjet cv | Ampilox cv | Ampoxin cv | Anticlav | Apcil | Aroclav | Auclan | Audiclav | Augduo | Augmentin | Augmexx | Augmox | Augnet | Augpen | Augremo | Augutroy | Augvo cv | Augwel | Aulanic | Ausmoclav | Axlam cv | Axn cv | Azamox cv | Bacimox cv | Bactoclav | Bactoclav es | Bactovan | Barclav | Barrister | Baxiclav | Benzoclav | Bestomax | Biclopen cv | Bilclav | Bilin plus | Bioclavid | Blumox-ca | Boostim | Boxyclav | Bruclav | C Mox | Caremox ag | Caremox ag 625 | Carolox cv | Cavmox | Cipclav | Cipmox cv | Clafect duo 625 | Clafel | Clamchek | Clamoff 375 | Clamox | Clamoxin | Clamp | Clanic | Clanoxy | Clarence | Clauvmentin | Clavace | Clavactum | Clavam | Clavam es | Clavax | Clavcare | Clavcare w | Clavcure | Clavek c | Clavid a | Clavid a 1000 | Clavidur | Clavifast | Clavimox | Clavit | Clavituf | Clavmark | Clavmentin | Clavmox | Clavobid | Clavosis | Clavotec | Clavotrol | Clavox | Clavoxone | Clavris c | Clavu m | Clavubit | Clavx | Clawin | Clazimox | Clearmox cv | Cledomox | Clevermox | Clompic cv | Clovista | Co cv | Coeamox 625 | Cosymoxyl | Curam | Delpoclav | Demoxin CV | Demoxin cv | Doiss | Doo clav | Dosclav | Duciclav | Duclav | Duet | Duomox | Duomox 625 | Duroclav | Ecomox cv | Enclav | Enclave | Enhancin | Eradiclav Duo | Erox CV | Estamox cv | Exario | Fection dd | Fection ds | Femexel | Figthox | Finemox cv | Finemox cv xr | Flamclov | Flemiclav | Fortclav | Gericlav | Gl 625 | Glanclav | Glyph cv | Godclav | Goldclav | Grandmox | Hhamclav | Hibrid | Ibiclav | Ibimox | Ibimox bd | Icpamox cv | Inclab 625 | Inclab dry syrup | Indclav | Iphaclav | Jonclav cv | Joyclav | Kastle | Kaymoxmentin | Kaziclav | Kilban | Klavocillin | Klclav | Koact | Konamox cv | Konqur | Kusamox | Kwikmox cv | Laciclav | Lacom cv | Lactoclaav | Lariclav | Larimox | Larimox 625 duo | Lymoxil cv | Magcil cv | Masterclav | Maxigem | Maximizin | Medimox cv | Medmox cv | Mega CV | Megaclav | Megamentin | Megamox CV | Meroxin | Miximox cv | Moclawin | Monamox cl | Monoclav | Mordica | Mox cv | Moxbio cv | Moxbro CV | Moxclav | Moxibond | Moxicom CV | Moxidas cv | Moxiease cv | Moxiforce cv | Moxigem | Moxikare | Moxikind cv | Moxileb cv | Moxilink c | Moxipic cv | Moxiplus cv | Moxivib cv | Moxiwiz cv | Moxlox CV | Moxmentin | Moxnecs clav | Moxodin cv | Moxreme cv | Moxxil duo | Moxxil Kid | Moxyclav | Moxylite cv | Moxynic | Moxyzen clav | Mpox CV | Mpx cv | Mucoclav | Multiclav | Mxson cv | Myclav | New numox | Nikomox-cv | Nova cv | Novaclav | Novamentin | Novamox CV | Nuclav | Oc clav | Octamox cv | Ogmen | Ogmios | Omniclav | Onamox Cl | One clav | Optimox cv | Pactel | Pd Mox C | Pedi ag | Penclav | Penhance | Penlactic | Pentamentin | Pexoclav | Polyclav | Powerclav | Pranmox cv | Pressclav | Princiclav | Proclav | Radimentin | Radimox cv | Rapiclav | Regs ac | Remiclav | Resiclav | Roclav | Roclav bd | Romox cl | Romox cv | Ronclav | Ronclav ds | Rozeclav | Rti Clav | Sagumin | Saimox CV | Samclav | Semox cv | Sensiclav | Septoclav | Sporiclav | Staclav | Sunclav | Surmox CV | Swiftclav | Symbiotik xl | Symbiotik-xl | Synclav | Tegamox Plus | Tervis | Themiclav ds | Threoclav | Tilmox cv | Topclav | Tormoxin clav | Tormoxin Clav | Toxo mox | Tresmox cv | Troclav | Truclave | Twinox | Ulticlav | Ultimox | Verclav | Vivobact | Vomox cv | Vulacin | Warclav | Wideclav | Xoclave | Xpand | Xtraclav | Xyclav | Xylomox cv | Yesmox CL | Zovax cv | Zoxil-CV | Zubact | Zyclav</span>;</li>
<li>
<span class="countryCode">(IQ)</span> <span class="country">Iraq</span><span class="countrySeparator">: </span><span class="drugName">Aumentin mdi | Moxclav</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Abba | Abioclav | Acadimox | Amocla | Amox+ac clav Acv | Amox+ac clav Alm | Amox+Ac Clav alter | Amox+Ac Clav Doc | Amox+Ac Clav EG | Amox+ac clav IBI | Amox+Ac Clav Mgi | Amox+ac clav ranb | Amox+ac clav ratio | Amox+Ac Clav San | Amox+ac clav San | Amox+Ac Clav Wip | Amox+ac clavul abc | Amoxic.ac.clavul. | Amoxicillina e acido clavulanico angenerico | Amoxicillina e acido clavulanico aurobindo | Amoxicillina e acido clavulanico bluefish | Amoxicillina e acido clavulanico eurogenerici | Amoxicillina e acido clavulanico Krka | Amoxicillina e acido clavulanico pfizer | Amoxicillina e acido clavulanico ratiopharm | Amoxicillina e acido clavulanico zentiva | Amoxicillina/Acido clavulanico | Anival | Augmentin | Augmentin bambini | Aveggio | Clautero | Clavomed | Clavulin | Euticlavir | Homer | Kruxade | Mondex | Moxivul | Neo Duplamox | Neoduplamox bambini | Posmox | Puriclav | Saromox | Stemox | Xinamod</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Augmentin | Auxlav | Clamoxin | Clavar | Clavodar | Curam | Gloclav | Julmentin | Julmentin 2x | Klamoks | Klavox | Megamox | Moxiclav | Ramoclav</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Augmentin | Augmentin combination</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Acinet | Amciclav | Amclamed | Amocin cla | Amoclan | Amoclan bid | Amoklavin | Amoxicillin and potassium clavulanate | Amoxiclav denk | Augmentin | Augmentin bd | Augmentin es | Augmin | Augpen | Augyclav | Bactoclav | Bactoclav 1000 | Bactoclav 375 | Bactoclav 625 | Bactrid ee | Beeclav | Cerobact | Cinclav | Cipclav | Clamoxin | Claneksi | Claneksi forte | Clanoxy | Clauviax | Clav | Clavall | Clavam | Clavam bid | Clavam forte | Clavamyn | Clavcon | Clavicin | Clavimox | Clavmark | Clavodar | Clavomid | Clavulin | Claxy | Cledomox | Coamox | Coamox acino | Corclav | Cosil | Curam | Dafraclav | Dioclav | Dumoclav | Emoxclav | Enhancin | Famoxiclav | Finemox cv | Fleming | Gamok | Hibiotic | Indclav | Injmentin | Julmentin | Julmentin 2x | Julmentin forte | Kamox clav | Klavmox | Koact | Labclav | Moxaclav | Moxiforce cv | Moxikind cv | Myclav | Neoclav | Novaclav | Numolav | Rapiclav | Redamox | Vemoxin cv | Winclav | Yumox cl | Zyclave</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">A clan | A clan duo | A clan neo | A cran | Acicla | Acicla duo | Acicla neo | Acla | Acla Duo | Acla neo | Aclan | Aclan duo | Aclantis | Aclantis duo | Aclao | Aclaon duo | Aclas | Acrentin duo | Acrentine | Acrentine duo | Ahacool | Ahacool duo | Aicillin duo | Aicillin s | Aircla duo | Amiclan | Amiclan Duo | Amocicle | Amocicle duo | Amocla | Amocla duo | Amocla neo | Amoclan | Amoclan duo | Amoclzen duo | Amocombi duo | Amocrin | Amoctasim | Amoctasim duo | Amoctasim neo | Amoctaxim | Amoctin | Amoctin duo | Amokcla | Amokcle | Amokcle duo | Amolanic | Amolanic duo | Amolanic es | Amomentin | Amoracillin | Amorex | Amorex duo | Amorex neo | Amosidal | Amosidal duo | Amov | Amovedy | Amoxa | Amoxa duo | Amoxalin | Amoxalin duo | Amoxalin neo | Amoxan duo | Amoxcl | Amoxcla | Amoxclan duo | Amoxclan neo | Amoxic | Amoxicla | Amoxicle | Amoxitin | Amoxitin duo | Amoxiyeon duo | Amoxklin duo | Amoxtacim neo | Anticlan | Anycla | Anycra | Anycra duo | Anycra neo | Auclan | Auclatin | Auclatin duo | Auclatin neo | Aucmectin | Augmac | Augmac duo | Augme | Augme duo | Augme neo | Augmen | Augmen duo | Augmentam | Augmenti s | Augmentin | Augmentin Duo | Augmex | Augmex duo | Augmex neo | Augtin | Augtin duo | Augtinneo | Augucillin | Augucillin duo | Augucla | Augumac | Augumac duo | Augutin | Augutin duo | Aumentin | Aumentin duo | Aumetin | Beacla | Bearcla | Bearcla duo | Bi cla duo | Bi cla neo | Bicla | Camodix | Camodix duo | Cj amocombi duo | Clabulo duo | Clacillin | Clacillin duo | Clacillin neo | Cladus | Clamax | Clamax duo | Clamax neo | Clamentin | Clamentin duo | Clamo | Clamo duo | Clamonex | Clamonex duo | Clamonexpotin | Clamox | Clamox duo | Clamox neo | Clamoxen | Clamoxen duo | Clamoxen neo | Clamoxil | Clamoxil duo | Clamoxin | Clamoxin duo | Clamoxin neo | Claoxin | Claoxin duo | Clarin duo | Clarin neo | Clarinneo | Classirine neo | Clavutin | Clavutin duo | Clavutine | Clavutine duo | Cloanan duo | Cloanan neo | Clumox duo | Cracizen duo | Cramax neo | Cramon | Cramon duo | Cramon neo | Cramotin | Cramotin duo | Cramoxin Duo | Crasigen | Croanan | Croanan dou | Croanan duo | Croanan neo | Curamus | Curamus duo | Ducla | Ducla duo | Duocla | Duocla neo | Duonex | Glocilin | Glocillin duo | Gumentin | Gumentin neo | Hucla | Huniz claduo | Huons amoxicla | Hwamocle | Hycla | Hycra | Hycra duo | Hycra neo | Hycraduo | Icillin | Icillin duo | Icillin s | Inist neo | Inxiclan | Inxiclan neo | K mentin duo | K mentine | K-cillin | Klavon | Klavon duo | Klavon neo | Kmoxilin | Kmoxilin 7/1 | Lactamox | Lactamox duo | Lactamox neo | Lamocla duo | Lamocrin | Lamocrin duo | Lamocrin neo | Lamoxilin | Liumox | Martin | Maxcillin | Maxcillin duo | Maxiclan | Maxiclan duo | Maxiclan neo | Maxicran duo | Maxilin | Maxilin duo | Medicla | Medicla duo | Moxamentin | Moxamentin Duo | Moxamentin neo | Moxicla | Moxiclan | Moxiclan duo | Moxicle | Moxicle duo | Moxicle neo | Moxiclen | Moxicra | Moxivl duo | Moxivl neo | Myungmoon amoclan | Myungmoon amoclan duo | Nanocra | Necmoclean | Necmoclean duo | Necmoclean neo | Neocla duo | Newcla | Newmokcra | Novoclan | Novoclan duo | O men | O men duo | Oclan duo | Oclan neo | Ocratin | Omecla | Omecla duo | Omecle | Omecle neo | Ometin | Ometin duo | Pamockle | Pamockle duo | Pencla | Pencra | Pencra duo | Penimentin | Pleming | Potacin | Potacin duo | Potacin neo | Priclan | Richmentin | Samjungtin | Tiramox | Tiramox s | Unicra | Yucla | Yucla duo | Yuhan amoxicillin clavulanate | Yuromentin | Yuromentin duo | Zakutex | Zakutex duo | Zakutex neo</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Augmentin | Clavamox | Clavodar | Clavomox | Coamox | Curam | Gloclav | Hibiotic | Julmentin | Julmentin 2x | Klavox | Neoclav</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Amoclan bid | Amoklavin | Amoklavin bid | Ardineclav | Augmacillin | Augmentin | Betamox | Calamox | Clavodar | Clavomid | Coamox | Curam | E moxclav | Enhancin | Fleming | Fugentin | Gloclav | Homer | Julmentin | Klavox | Klavunat bid | Klavunat es | Megamox | Moxiclav | Moxiclav bis | Moxiclav forte | Ogmentinine | Panklav | Panklav Forte</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Amoksiklav 2x | Amoxicillin/clavulanic acid actavis | Amoxicillin/Clavulanic acid Siromed | Aniclav | Apomox | Augmentin | Augmentin DDS | Augmentin Duo | Augmentin es | Betaklav | Clavam xr | Curam | Elmox cv | Enhacin | Formox cv | John clav | Klavocin | Medoclav | Moxiclav</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Amoclane eg | Amoxiclav | Amoxiclav Sandoz | Augmentin | Clavucid | Docamoclaf</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Amoksiklav 2x | Amoxicillin/clavulanic acid aurobindo | Augmentin | Augmentin bis | Augmentin mf | Avidia | Betaklav | Curam | Enhancin | Medoclav | Taromentin</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Aclav | Amoclavin | Augmentin | Biotic plus | Clavulin | Co amoxiclav | Curam | Ecoclav | Levamox | Maxiclav | Neoclav | Novoclin | Saphir | Soclav | Zamox</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Acarbixin | Acimox ac | Alvi Tec | Amobay cl | Amoxic+a-clav.gi k | Amoxicil-clavul gi | AMOXICILINA + ACIDO CLAVULANICO | Amoxiclav | Amoxiclav bid | Ampliron Duo | Apoclavox | Augmentin | Augmentin 12 h | Augmentin 12h | Augmentin es | Avuxilan | Caxicum | Clambusil | Clamicil | Clamoval | Clamoxin | Clamoxin 12h | Clamoxin s | Clavant-bid | Clavipen | Clavipen 12h | Clavucyd | Clavucyd bid | Clavulin | Clavulin 12H | Clavuser | Clavuser 12 hrs | Crizmat | Eumetinex | Gimaclav | Gramaxin | Moxlin clv | Penamox 12h duo | Polymox aebal | Polymox duo | Polymox duo 12h | Rapiclav | Servamox clv | Servamox clv 12h | Sinufin | Valclan</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Alvonal | Amocla | Amoxicillin and clavulanate potassium | Amoxiclav | Augmentin | Clamentin | Clamonex | Clamovid | Clamox | Clavam | Clavicin | Clavomax | Clavomid | Cledomox | Co amoxiclav | Co amoxiclav kapl | Co-amoxiclav pharmaniaga | Co-Amoxiclave pharmaniaga | Curam | Enhancin | Fleming | Fugentin | Koact | Moxiclav | Myclav | Rapiclav | Vestaclav | Xinclav</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Adaclav | Adventin | Africlav | Agcloxtin | Amclavin | Amovin | Amoxicillin &amp; clavulanate potassium | Amoxicillin &amp; clavulanic acid | Amoxicillin and clavulanate potassium | Aquaclav | Astamentin | Auglocef | Augmentin | Augulab | Aviclav | Axitin | Benclav | Betalac ac | Betamoclacid | Bg clav | Bond co amoxyclav | Chazmax co amoxiclav | Chemoclav | Chosementin | Clamoxin | Clavamox | Clavatin | Clavugen | Clavulin | Clavulist | Co amoxiclav | Coamoxiclav marcolivia | Digiclav 228 | Digiclav 625 | Dumoclav | Ebeclav | Eglomentin | Exaclav | Fhl co amoxiclav | Foxiclov | G clav | Geozin | Gimbaclav | Imoxclav | Kenop | Koact | Lifeclav | Loxaclav | Lynxiclav | Malmentin | Mannyclav | Maryclantin | Mecure amoxicillin &amp; clavulanic acid | Medoclav | Meem amoxicillin and clavulanate acid | Mentclav | Moko amoxicillin &amp; clavulanate potassium | Moko amoxicillin &amp; clavulanic potassium | Moxymentin | Myclav | Namoxyclav | Nectaclav | Nosclav | Obiclaf | Oroclav | Oxclav | Oxclav forte | Oxynic | Pemaclav | Qualiclav | Rapiclav | Reboklav | Recvanic | Royaclav | Sampravam | Sanclaf | Spectracluvenic | Spingumentin | Sugam | Supermentin | Theoclav | Vistin | Xomox cv | Xymentin | Zamox c | Zamoxc | Zanitin duo | Zeroclav | Ziclav | Zimilat | Zooclav</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Amoxi clavulan stada | Amoxicilline/Clavulaanzuur | Amoxicilline/Clavulaanzuur A | Amoxicilline/Clavulaanzuur Actavis | Amoxicilline/Clavulaanzuur Alpharma | Amoxicilline/clavulaanzuur Apotex | Amoxicilline/Clavulaanzuur aristo | Amoxicilline/Clavulaanzuur Aurobindo | Amoxicilline/clavulaanzuur cf | Amoxicilline/Clavulaanzuur Merck | Amoxicilline/Clavulaanzuur Mylan | Amoxicilline/Clavulaanzuur PCH | Amoxicilline/clavulaanzuur ratiopharm | Amoxicilline/clavulaanzuur sandoz | Amoxicilline/Clavulaanzuur Sandoz | Augmentin | Augmentine</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Amoclav | Amoxi-clav stada | Amoxiclav | Amoxiclav 1a pharma | Amoxiclav hikma | Augmentin | Bioclavid | Co amoxiclav | Co-amoxiclav | Spektramox</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Alpha-amoxyclav | Augmentin | Curam | M amoxiclav | Synermox</span>;</li>
<li>
<span class="countryCode">(OM)</span> <span class="country">Oman</span><span class="countrySeparator">: </span><span class="drugName">Dioclav</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Aciclav | Alfamox ac | Ambilan | Amolex | Amoxibac cl | AMOXICILINA + ACIDO CLAVULANICO | Amoxiclin CL 12h | Amoxidal plus | Amoxidin cl | Amoxyseven | Augmentin | Augmentin es | Augmex duo | Augmox | Bioxilina plus | Bramoxal duo | Broncobiotic cl | Clavam duo | Clavicel | Clavinex | Clavoxilin plus | Clavoxilin plus forte | Clavukem | Clavulex | Clavuliph duo | Clavumass | Clavumox | Clavunil | Clavutrim cl | Curam | Deltamox cl | Enhancin | Medimoxilin cl | Movulan | Orabiot CL | Proflox cl | Velamox cl</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Addex | Agcomen | Agpen | Alclav | Alclav DS 457 | Altoclav | Altocom | Altovox | Alvonal | Amamcla | Ambiclav | Amoclav | Anbicyn | Antclav | Arvoclav | Atadar | Auget | Augmentin | Augmex | Augurcin | Aumox | Axalav | Bactiv | Bactoclav | Bioclav | Bioclavid | Cavumox | Cax | Clamovid | Clamoxid | Clamoxin | Claneksi | Clanoxy | Claventin | Claverob | Clavinyx | Clavistan | Clavmed | Clavmex | Clavmoxwel | Clavomax | Clavorex | Clavox | Clavoxel | Clavoxtin | Clavsin | Clavuclav | Clovimax | Clovimed | Clovintin | Clovoxclav | Co amoxiclav | Co avox | Co Ax | Co-amoxiclav | Cobiomax | Comox | Comoxitab | Comxicla | Cosmox | Cowamox | Cozeal | Descari | Duoclav | Eleventin | Endclav | Enhancin | Eoclav | Euroclav | Exten | Fleming | Genclav | Geoxiclav | Globantin | Gloclav | Goclav | Gomox | Gravimox | Inoclav | Jamoxi | Julmentin | Klavic | Kmoxilin | Koact | Lewiclav | Lezclav | Lox | Luvmox | Maxlavco | Mediclav | Megaclav | Moxclatab | Moxgen | Myclav | Nahaltin | Natravox | Nexilav | Pediaclav | Pencla | Penhance | Prevaclav | Proviclav | Proxiclav | Qualiclav | Rafonex | Raniclav | Rapiclav | Rhea co amoxiclav | Solclav | Sovlan | Stalmox cl | Sullivan | Truclav | Vexiclav | Viamox | Vispoclav | Xilanic</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Amclav | Amoxynate | Amoxynate dry suspension | Augmentin | Augmex | Augmiclav | Calamox | Calamox Duo | Clamentin | Clamoxin | Clatimox | Clav | Clavopin | Clavumox | Co amoxi | Co amoxi bd | Fortecin | Klavutin | Mentin og | Potentin | Rite | Stamentin | Stamentin ds | Stamentin duo | Stavomox | Termibex | Vulamox | Zamoclav</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Amoxicillin + Clavulanic Acid Aurovitas | Amylan | Auglavin | Auglavin pph | Augmentin | Co amoxiclav | Curam | Forcid | Hiconcil combi | Penlac | Polamoklav | Ramoclav | Recute | Taromentin</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilin clav/pot | Amoxicillin &amp; clavulanate k | Amoxicillin and clavulanate potassium | Amoxicillin and clavunate potassium | Amoxicillin trihydrate and clavulanate potassium | Amoxicillin/Clav pot | Augmentin</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Amoclavam | Amoxicilina + Acido Clavula. Sandoz | AMOXICILINA + ACIDO CLAVULANICO | Amoxicilina + Acido Clavulanico Alter | Amoxicilina + acido clavulanico aurobindo | Amoxicilina + acido clavulanico basi | Amoxicilina + acido clavulanico bluepharma | Amoxicilina + acido clavulanico bluesar | Amoxicilina + Acido clavulanico Ciclum | Amoxicilina + acido clavulanico combino | Amoxicilina + acido clavulanico generis | Amoxicilina + acido clavulanico Generis | Amoxicilina + acido clavulanico hikma | Amoxicilina + Acido Clavulanico Normon | Amoxicilina + acido clavulanico Pharmakern | Amoxicilina + Acido clavulanico Tarmix | Amoxicilina + acido clavulanico Tolife | Amoxicilina + acido clavulanico zentiva | Augmentin | Augmentin Duo | Betamox | Clavamox | Clavamox DT | Clavepen | Penilan</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Ambilan bid | Ambilan bid forte | Amox duo | Amoxicilina acido clavulanico sandoz | Amoxidal plus | Amoxidal plus duo | Anamox clav | Clavinex duo | Clavinex duo forte | Clavulox | Medamox beta | Trixan plus duo</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Amoclan BID | Amoclan Forte | Amoclan IV | Amoklavin | Amoklavin ES | Augmentin | Augmentin ES | Augmentin Infant Drops | Augmentin IV | Augmentin SR | Clavodar | Clavodar ES | Clavomox | Curam | Curam IV | Dioclav | E-Moxclav | Enhancin | Gloclav | Hibiotic | Julmentin | Julmentin 2X | Julmentin Forte | Julmentin IV | Klamoks BID 625 | Klamoks BID Fort | Klamoks BID Fort 1000 | Klavox | Koact 1000 | Koact 625 | Medaclav | Megamox | Moxiclav | Neoclav | Ramoclav</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Amoksiklav 2x | Amoxicilina/acid clavulanic aurobindo | Amoxicilina/acid clavulanic krka | Amoxiplus | Augmentin | Augmentin bis | Augmentin es | Augmentin fp | Augmentin sr | Bioclavid | Enhancin</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Amoclan hexal | Amoclavin | Amoksiklav | Amovicomb | Amoxicillin trihydrate and potassium clavulanate | Amoxicillin+clavulanic acid | Amoxicillin+clavulanic acid pfizer | Amoxicillin+clavulanic acid vial | Amoxiclav | Amoxivan | Arlet | Augmentin | Augmentin es | Augmentin sr | Bactoclav | Betaklav | Clamosar | Ecoclav | Fibell | Foraclav | Foraklav | Klavocin | Liclav | Medoclav | Moxiclav | Novaclav | Panklav | Panklav 2x | Ranclav | Rapiclav | Verklav</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Augmentin | Augmentin sr | Augmoks | Clamoxe | Clavodar | Coamox | Curam | Gloclav | Julmentin | Julmentin ES | Klavox | Medaclav | Megamox | Megamox es | Moxiclav | Ogmant | Oxiclav | Ramoclav</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Amoxicillin/clavulanic acid actavis | Amoxicillin/clavulanic acid aurobindo | Amoxicillin/Clavulanic acid BB | Amoxicillin/Klavulansyra 2care4 | Amoxicillin/Klavulansyra Amneal | Amoxicillin/klavulansyra ebb | Betaklav | Bioclavid | Klaximol | Spektramox</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Amocla | Anbicyn | Augmentin | Augmex | Clamonex | Clamovid | Co-amoxiclav | Curam | Enhancin | Fleming | Fugentin | Koact | Moxiclav</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Amoksiklav | Augmentin | Betaklav | Betaklav S | Klavocin</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Afreloxa | Amoksiklav | Amoxicillin/clavulanic acid mylan | Amoxicillin/clavulanic acid olikla | Augmentin | Betaklav | Betalactin | Curam | Enhancin | Medoclav | Megamox | Megamox BID | Penlac</span>;</li>
<li>
<span class="countryCode">(SL)</span> <span class="country">Sierra Leone</span><span class="countrySeparator">: </span><span class="drugName">Augmentin | Clamoxin | Clavesk</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">A clav 457 | Acinet | Amk | Amocla | Amoksiklav | Amotin | Amoxclav | Anbicyn | Atmovin | Augclav | Augmentin | Augmentin es | Augpen | Avacan | Bactoclav 375 | Biclav | Cavumox | Clamax | Clanoxy | Clavam | Claventin | Clavicin | Clavico | Clavomid | Clavulin | Coklav | Curam | Fleming | Indclav | Julmentin | Koact | Manclamine | Moxiclav | Moxicle | Oxpen | Ranclav | S clav | Starclav</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Amoxi clav zentiva | Amoxi-clav | Augmentin | Ciblor | Clavor | Mediclav | Novaclav | Vaamox</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Amoklavin | Amoksilav | Augmentin | Augmentin BID | Bioment | Bioment-bid | Croxilex | Croxilex-BID | Klamoks | Klavon | Klavon bid | Klavunat | Klavunat es | Klavupen</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Amoclan | Amoclav | Amoclavunin | Anbicyn | Augcin | Augmentin | Curam | Moxiclav | Soonmelt</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">A klav | Abiklav | Amoksiklav | Amoksiklav 2s | Amoksiklav 2x | Amoxicillin+clavulanic acid | Amoxicomb | Amoxil k | Amoxil k 1000 | Amoxil k 625 | Amoxypus | Augmentin | Augmentin bd | Augmentin es | Augmentin sr | Bactoclav | Betaklav | Clavam | Coact | Klamoks bid | Klavamitin | Medoclav | Medoclav forte | Panclav</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Acinet | Amoxiclav denk | Augmentin | Augmentin bd | Augmentin es | Bactoclav | Bactoclav 1000 | Bactoclav 375 | Bactoclav 625 | Clanoxy | Clavace | Clavam | Clavicin | Clavodar | Clavomid | Clavulin | Claxy | Cledomox | Co amox acino | Fleming | Julmentin | Koact | Magnabiotic | Moxikind | Myclav | Novaclav | Rapiclav | Redamox | S augpro | Spotclav | Spotclav os | Synclav | Syntoclav | Vexapen cp | Wocklav | Xomox cv</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilina Clavulanico Winpharm | Amoxidal plus | Amoxidal plus duo | Augmentin | Clavutam | Cluvax | Curam | Dibional | Fabamox duo | Sinot Clav</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Amitrexyl-ac | Amoclav | Amoklavin bid | Amoxicilina + acido clavulonico | Amoxicilina + clavulanato de potassio | Amoxicilina acido clavulanico | Amoxicilina con acido clavulanico | Amoxicilina/ clavulonico | Amoxival a.c. | Amoxyplus | Augmentin | Bioclav | Clavoxilin plus | Clavulam | Clavumedc | Clavumox | Curam | Exovis duo | Fulgram | Klamoks | Ranclav</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Amogentine | Auclanityl | Augbest | Augbidil | Augclamox | Aumakin | Clavart | Enhamox | Imefed | Klamentin | Klamex | Klavunamox | Kuniclav | Nacova dt | Ofmantine | Tedavi | Vigentin</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Actimentin | Adco amoclav | Apex clavutin | Apoclav | Augmaxcil | Augmentin | Augmentin sr | AUGSPEC | Auro amoxiclav | Austell co amoxiclav | Avutan | Betaclav | Bindoclav | Bio-amoksiklav | Camox co amoxiclav | Clamentin | Clavumox | CO AMOXICLAV TRINITY | Co amoxyclav bd austell | Co amoxyclav bd camox | Curam | Forcid | Gulf amoxy co | Moxyclav | Myclav | Ranclav | Rolab-amoclav | Rolab-co-amoxyclave | Sandoz Co-amoxyclav</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Acinet | Amoxiclav | Amoxiclav denk | Augmentin | Augmentin bd | Augpen | Bactoclav | Clanoxy | Clauviax | Clavulin | Cledomox | Dafraclav | Enhancin | Koact | Moxikind cv | Moxileb cv | Myclav | Novaclav | Rapiclav | Sandoz co amoxyclav | Zanitin | Zanitin duo</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Augmentin bd | Augmentine sr | Augumentin es | Co-amoxiclav | Enhancin | Myclav | Rapiclav</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-31958969">
<a name="31958969"></a>Afolabi TM, Goodlet KJ, Fairman KA. Association of antibiotic treatment duration with recurrence of uncomplicated urinary tract infection in pediatric patients. <i>Ann Pharmacother</i>. 2020;54(8):757-766. doi:10.1177/1060028019900650<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31958969/pubmed" id="31958969" target="_blank">31958969</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30078376">
<a name="30078376"></a>Agamennone V, Krul CAM, Rijkers G, Kort R. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands. <i>BMC Gastroenterol</i>. 2018;18(1):103. doi:10.1186/s12876-018-0831-x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30078376/pubmed" id="30078376" target="_blank">30078376</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27891788">
<a name="27891788"></a>Ailes EC, Gilboa SM, Gill SK, et al. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011. <i>Birth Defects Res A Clin Mol Teratol</i>. 2016;106(11):940-949. doi:10.1002/bdra.23570<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27891788/pubmed" id="27891788" target="_blank">27891788</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28619975">
<a name="28619975"></a>Akanbi O, Saleem N, Soliman M, Pannu BS. Antibiotic-associated haemorrhagic colitis: not always <i>Clostridium difficile</i>. <i>BMJ Case Rep</i>. 2017;2017:bcr2017219915. doi:10.1136/bcr-2017-219915<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28619975/pubmed" id="28619975" target="_blank">28619975</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.2021">
<a name="AAP.2021"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. <i>Red Book: 2021 Report of the Committee on Infectious Diseases</i>. 32nd ed. American Academy of Pediatrics; 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.2018">
<a name="AAP.2018"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Brady MT, Jackson MA, Long SA, eds. <i>Red Book: 2018 Report of the Committee on Infectious Diseases</i>. 31st ed. American Academy of Pediatrics; 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21873693">
<a name="21873693"></a>American Academy of Pediatrics (AAP) Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. <i>Pediatrics</i>. 2011;128(3):595-610.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21873693/pubmed" id="21873693" target="_blank">21873693</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32080050">
<a name="32080050"></a>American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins-Obstetrics. Prelabor rupture of membranes: ACOG practice bulletin, number 217. <i>Obstet Gynecol</i>. 2020;135(3):e80-e97. doi:10.1097/AOG.0000000000003700<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32080050/pubmed" id="32080050" target="_blank">32080050</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.2018.12">
<a name="Amoxicillin.2018.12"></a>Amoxicillin and clavulanate potassium tablets and oral suspension [prescribing information]. Princeton, NJ: Bionpharma Inc; September 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.2020.01">
<a name="Amoxicillin.2020.01"></a>Amoxicillin and clavulanate potassium injection [product monograph]. Boucherville, Quebec, Canada: Sandoz Canada Inc; January 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.2021.06">
<a name="Amoxicillin.2021.06"></a>Amoxicillin and clavulanate potassium oral suspension [product monograph]. Toronto, Ontario, Canada: Apotex Inc; June 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.2021.09">
<a name="Amoxicillin.2021.09"></a>Amoxicillin and clavulanate potassium tablet and oral suspension [prescribing information]. Princeton, NJ: Bionpharma Inc; September 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.2022.08">
<a name="Amoxicillin.2022.08"></a>Amoxicillin and clavulanate potassium tablet, oral suspension, and chewable tablet [prescribing information]. Bristol, TN: USAntibiotics, LLC; August 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27060684">
<a name="27060684"></a>Anderson PO, Sauberan JB. Modeling drug passage into human milk. <i>Clin Pharmacol Ther</i>. 2016;100(1):42-52.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27060684/pubmed" id="27060684" target="_blank">27060684</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16083708">
<a name="16083708"></a>Andrade RJ, Lucena MI, Fernández MC, et al; Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. <i>Gastroenterology</i>. 2005;129(2):512-521. doi:10.1016/j.gastro.2005.05.006 [Erratum in: <i>Gastroenterology</i>. 2005;129(5):1808.]<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/16083708/pubmed" id="16083708" target="_blank">16083708</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7141752">
<a name="7141752"></a>Arancibia A, Drouguett MT, Fuentes G, et al. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function. <i>Int J Clin Pharmacol Ther Toxicol.</i> 1982;20(10):447-453.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/7141752/pubmed" id="7141752" target="_blank">7141752</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32246774">
<a name="32246774"></a>Ariza A, Fernández-Santamaría R, Meng X, et al. Characterization of amoxicillin and clavulanic acid specific T-cell clones from patients with immediate drug hypersensitivity. <i>Allergy</i>. 2020 Apr 4. doi:10.1111/all.14298<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32246774/pubmed" id="32246774" target="_blank">32246774</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31781425">
<a name="31781425"></a>Armas Villalba A, Haq M, Zhang C, Thakkar J. Amoxicillin/Clavulanic acid-induced agranulocytosis: A case report and review of the literature. <i>Case Rep Hematol</i>. 2019;2019:5718716. doi:10.1155/2019/5718716<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31781425/pubmed" id="31781425" target="_blank">31781425</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Aronoff.2007">
<a name="Aronoff.2007"></a>Aronoff GR, Bennett WM, Berns JS, et al, eds. <i>Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children</i>. 5th ed. American College of Physicians; 2007.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33716294">
<a name="33716294"></a>Asim M, Ahmad F, Akhtar M. Florid Interstitial Hemorrhages: A novel feature of amoxicillin-clavulanate-induced acute tubulointerstitial nephritis. <i>Am J Case Rep</i>. 2021;22:e928989. doi: 10.12659/AJCR.928989<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/33716294/pubmed" id="33716294" target="_blank">33716294</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Augmentin.2019.01">
<a name="Augmentin.2019.01"></a>Augmentin (amoxicillin/clavulanate potassium) [prescribing information]. Bristol, TN: US Antibiotics LLC; August 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AugmentinES.2012.12">
<a name="AugmentinES.2012.12"></a>Augmentin ES-600 powder (amoxicillin and clavulanate potassium) [prescribing information]. Bristol, TN: US Antibiotics LLC; September 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AugmentinXR.2014.04">
<a name="AugmentinXR.2014.04"></a>Augmentin XR (amoxicillin and clavulanate potassium) [prescribing information]. Bridgewater, NJ: Dr Reddys Laboratories Inc; April 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AugmentinXR.2022.11">
<a name="AugmentinXR.2022.11"></a>Augmentin XR (amoxicillin and clavulanate potassium) [prescribing information]. Briston, TN: US Antibiotics, LLC; November 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Baddour.2021a">
<a name="Baddour.2021a"></a>Baddour LM, Harper M. Animal bites (dogs, cats, and other mammals): Evaluation and management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 3, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Baddour.2021b">
<a name="Baddour.2021b"></a>Baddour LM, Harper M. Human bites: evaluation and management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed September 27, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29292282">
<a name="29292282"></a>Balighian E, Burke M. Urinary tract infections in children. <i>Pediatr Rev</i>. 2018;39(1):3-12. doi:10.1542/pir.2017-0007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29292282/pubmed" id="29292282" target="_blank">29292282</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27080992">
<a name="27080992"></a>Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. <i>Clin Infect Dis</i>. 2016;62(10):e51-e77. doi:10.1093/cid/ciw118.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27080992/pubmed" id="27080992" target="_blank">27080992</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30302990">
<a name="30302990"></a>Barni S, Mori F, Fili L, Parronchi P, Novembre E. Amoxicillin/clavulanic acid-induced exfoliative dermatitis in a child. <i>Minerva Pediatr</i>. 2018;70(5):495-496. doi: 10.23736/S0026-4946.17.04845-9<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30302990/pubmed" id="30302990" target="_blank">30302990</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Barshak.1">
<a name="Barshak.1"></a>Barshak MB. Antimicrobial approach to intra-abdominal infections in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed April 13, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11821511">
<a name="11821511"></a>Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. <i>N Engl J Med</i>. 2002;346(5):334-339. doi:10.1056/NEJMcp011603<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/11821511/pubmed" id="11821511" target="_blank">11821511</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26089185">
<a name="26089185"></a>Belver MT, Michavila A, Bobolea I, Feito M, Bellón T, Quirce S. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS). <i>Allergol Immunopathol (Madr)</i>. 2016;44(1):83-95. doi:10.1016/j.aller.2015.02.004<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26089185/pubmed" id="26089185" target="_blank">26089185</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16044108">
<a name="16044108"></a>Benyamini L, Merlob P, Stahl B, et al. The Safety of Amoxicillin/Clavulanic Acid and Cefuroxime During Lactation. <i>Ther Drug Monit</i>. 2005;27(4):499-502.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/16044108/pubmed" id="16044108" target="_blank">16044108</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32365216">
<a name="32365216"></a>Betschart C, Albrich WC, Brandner S, et al. Guideline of the Swiss Society of Gynaecology and Obstetrics (SSGO) on acute and recurrent urinary tract infections in women, including pregnancy. <i>Swiss Med Wkly</i>. 2020;150:w20236. doi:10.4414/smw.2020.20236<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32365216/pubmed" id="32365216" target="_blank">32365216</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23732265">
<a name="23732265"></a>Biondo S, Golda T, Kreisler E, et al. Outpatient versus hospitalization management for uncomplicated diverticulitis: a prospective, multicenter randomized clinical trial (DIVER trial). <i>Ann Surg</i>. 2014;259(1):38-44. doi:10.1097/SLA.0b013e3182965a11<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23732265/pubmed" id="23732265" target="_blank">23732265</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23419359">
<a name="23419359"></a>Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. <i>Gastroenterology</i>. 2013;144(7):1419-1425, 1425.e1-3; quiz e19-20. doi:10.1053/j.gastro.2013.02.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23419359/pubmed" id="23419359" target="_blank">23419359</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25913298">
<a name="25913298"></a>Blanca-Lopez N, Perez-Alzate D, Ruano F, et al. Selective immediate responders to amoxicillin and clavulanic acid tolerate penicillin derivative administration after confirming the diagnosis. <i>Allergy</i>. 2015;70(8):1013-1019. doi:10.1111/all.12636<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25913298/pubmed" id="25913298" target="_blank">25913298</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30558872">
<a name="30558872"></a>Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. <i>Lancet</i>. 2019;393(10167):183-198. doi:10.1016/S0140-6736(18)32218-9<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30558872/pubmed" id="30558872" target="_blank">30558872</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26598097">
<a name="26598097"></a>Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. <i>Pharmacotherapy</i>. 2015;35(11):1052-1062.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26598097/pubmed" id="26598097" target="_blank">26598097</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21880587">
<a name="21880587"></a>Bradley JS, Byington CL, Shah SS, et al. The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2011;53(7):e25-e76.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21880587/pubmed" id="21880587" target="_blank">21880587</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12182396">
<a name="12182396"></a>Bradley JS. Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines. <i>Pediatr Infect Dis J</i>. 2002;21(6):592-598.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/12182396/pubmed" id="12182396" target="_blank">12182396</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bradley.1">
<a name="Bradley.1"></a>Bradley JS, Nelson JD, Kimberlin DK, et al, eds. <i>Nelson's Pocket Book of Pediatric Antimicrobial Therapy</i>. 28th ed. American Academy of Pediatrics; 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24503131">
<a name="24503131"></a>Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by <i>Clostridium difficile</i>. <i>Gastroenterology</i>. 2014;146(6):1547-1553. doi:10.1053/j.gastro.2014.01.059<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/24503131/pubmed" id="24503131" target="_blank">24503131</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26120552">
<a name="26120552"></a>Brockow K, Przybilla B, Aberer W, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). <i>Allergo J Int</i>. 2015;24(3):94-105. doi:10.1007/s40629-015-0052-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26120552/pubmed" id="26120552" target="_blank">26120552</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23478961">
<a name="23478961"></a>Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated <i>Clostridium difficile</i> infection. <i>Antimicrob Agents Chemother</i>. 2013;57(5):2326-2332. doi:10.1128/AAC.02176-12<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23478961/pubmed" id="23478961" target="_blank">23478961</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32069358">
<a name="32069358"></a>Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative <i>C. difficile</i> infection risks: a longitudinal case-cohort study. <i>Clin Infect Dis</i>. 2020:ciaa124. doi: 10.1093/cid/ciaa124<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32069358/pubmed" id="32069358" target="_blank">32069358</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2049243">
<a name="2049243"></a>Campbell AC, McElnay JC, Passmore CM. The excretion of ampicillin in breast milk and its effect on the suckling infant. Proceedings of the British Pharmacological Society. September 12-14, 1990, Belfast. <i>Br J Clin Pharmacol</i>. 1991;31(2):230P. doi:10.1111/j.1365-2125.1991.tb05523.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/2049243/pubmed" id="2049243" target="_blank">2049243</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23039319">
<a name="23039319"></a>Casey JR, Block SL, Hedrick J, Almudevar A, Pichichero ME. Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media. <i>Drugs</i>. 2012;72(15):1991-1997. doi:10.2165/11590320-000000000-00000<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23039319/pubmed" id="23039319" target="_blank">23039319</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.2020">
<a name="CDC.2020"></a>Centers for Disease Control and Prevention (CDC). FAQs for clinicians about <i>C. diff</i>. <a href="https://www.cdc.gov/cdiff/clinicians/faq.html" target="_blank">https://www.cdc.gov/cdiff/clinicians/faq.html</a>. March 27, 2020. Accessed May 6, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18955056">
<a name="18955056"></a>Chalasani N, Fontana RJ, Bonkovsky HL, et al; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. <i>Gastroenterology</i>. 2008 Dec;135(6):1924-34, 1934.e1-4. doi: 10.1053/j.gastro.2008.09.011<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/18955056/pubmed" id="18955056" target="_blank">18955056</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24935270">
<a name="24935270"></a>Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. <i>Am J Gastroenterol</i>. 2014;109(7):950-966.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/24935270/pubmed" id="24935270" target="_blank">24935270</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30071846">
<a name="30071846"></a>Chams S, El Sayegh S, Hamdon M, Kumar S, Tegeltija V. Amoxicillin/clavulanic acid-induced pancreatitis: case report. <i>BMC Gastroenterol</i>. 2018;18(1):122. doi: 10.1186/s12876-018-0851-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30071846/pubmed" id="30071846" target="_blank">30071846</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30556617">
<a name="30556617"></a>Chandler RE. Increased risk for aseptic meningitis after amoxicillin or amoxicillin-clavulanic acid in males: a signal revealed by subset disproportionality analysis within a global database of suspected adverse drug reactions. <i>Pharmacoepidemiol Drug Saf</i>. 2019;28(3):389-395. doi: 10.1002/pds.4707<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30556617/pubmed" id="30556617" target="_blank">30556617</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22438350">
<a name="22438350"></a>Chow AW, Benninger MS, Brook I, et al; Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. <i>Clin Infect Dis</i>. 2012;54(8):e72-e112.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22438350/pubmed" id="22438350" target="_blank">22438350</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Chow.2019">
<a name="Chow.2019"></a>Chow AW. Complications, diagnosis, and treatment of odontogenic infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 9, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clavulin.2020.08">
<a name="Clavulin.2020.08"></a>Clavulin (amoxicillin and clavulanic acid) [product monograph]. Mississauga, Ontario, Canada: GlaxoSmithKline Inc; November 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24755188">
<a name="24755188"></a>Collins CE, Ayturk MD, Flahive JM, Emhoff TA, Anderson FA Jr, Santry HP. Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries. <i>J Am Coll Surg</i>. 2014;218(6):1141-1147.e1. doi: 10.1016/j.jamcollsurg.2014.01.053<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/24755188/pubmed" id="24755188" target="_blank">24755188</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27387793">
<a name="27387793"></a>Confino-Cohen R, Rosman Y, Lachover I, Meir Shafrir K, Goldberg A. The importance of amoxicillin and amoxicillin-clavulanate determinants in the diagnosis of immediate allergic reactions to β-Lactams. <i>Int Arch Allergy Immunol</i>. 2016;170(1):62-66. doi: 10.1159/000446961<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27387793/pubmed" id="27387793" target="_blank">27387793</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32390163">
<a name="32390163"></a>Copaescu A, Rose M, Mouhtouris E, Chua KY, Holmes NE, Phillips EJ, Trubiano JA. Delayed hypersensitivity associated with amoxicillin-clavulanate. <i>Allergy</i>. 2020;75(10):2700-2702. doi: 10.1111/all.14359<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32390163/pubmed" id="32390163" target="_blank">32390163</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30589457">
<a name="30589457"></a>Crass RL, Pai MP. Pharmacokinetics and pharmacodynamics of β-lactamase inhibitors. <i>Pharmacotherapy</i>. 2019;39(2):182-195. doi:10.1002/phar.2210<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30589457/pubmed" id="30589457" target="_blank">30589457</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19884587">
<a name="19884587"></a>Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. <i>Arch Pediatr Adolesc Med</i>. 2009;163(11):978-985. doi:10.1001/archpediatrics.2009.188<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19884587/pubmed" id="19884587" target="_blank">19884587</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2667333">
<a name="2667333"></a>Dagan R, Bar-David Y. Comparison of amoxicillin and clavulanic acid (augmentin) for the treatment of nonbullous impetigo. <i>Am J Dis Child</i>. 1989;143(8):916-918. doi:10.1001/archpedi.1989.02150200068020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/2667333/pubmed" id="2667333" target="_blank">2667333</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31260651">
<a name="31260651"></a>Damkier P, Brønniche LMS, Korch-Frandsen JFB, Broe A. In utero exposure to antibiotics and risk of congenital malformations: a population-based study. <i>Am J Obstet Gynecol</i>. 2019;221(6):648.e1-648.e15. doi:10.1016/j.ajog.2019.06.050<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31260651/pubmed" id="31260651" target="_blank">31260651</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3190988">
<a name="3190988"></a>Davies BE, Boon R, Horton R, Reubi FC, Descoeudres CE. Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin. <i>Br J Clin Pharmacol</i>. 1988;26(4):385-390. doi:10.1111/j.1365-2125.1988.tb03395.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/3190988/pubmed" id="3190988" target="_blank">3190988</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27003146">
<a name="27003146"></a>deLemos AS, Ghabril M, Rockey DC, et al; Drug-Induced Liver Injury Network (DILIN). Amoxicillin-clavulanate-induced liver injury. <i>Dig Dis Sci</i>. 2016;61(8):2406-2416. doi:10.1007/s10620-016-4121-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27003146/pubmed" id="27003146" target="_blank">27003146</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32360431">
<a name="32360431"></a>de Rossi P, Cimerman S, Truzzi JC, et al. Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women. <i>Braz J Infect Dis</i>. 2020;24(2):110-119. doi:10.1016/j.bjid.2020.04.002<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32360431/pubmed" id="32360431" target="_blank">32360431</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36669519">
<a name="36669519"></a>de Wijkerslooth EML, Boerma EG, van Rossem CC, et al; APPIC Study Group. 2 days versus 5 days of postoperative antibiotics for complex appendicitis: a pragmatic, open-label, multicentre, non-inferiority randomised trial. <i>Lancet</i>. 2023;401(10374):366-376. doi:10.1016/S0140-6736(22)02588-0<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/36669519/pubmed" id="36669519" target="_blank">36669519</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30664553">
<a name="30664553"></a>Desai M, Fathallah J, Nutalapati V, Saligram S. Antibiotics versus no antibiotics for acute uncomplicated diverticulitis: a systematic review and meta-analysis.<i> Dis Colon Rectum.</i> 2019;62(8):1005-1012. doi:10.1097/DCR.0000000000001324<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30664553/pubmed" id="30664553" target="_blank">30664553</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23620467">
<a name="23620467"></a>Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Sferra TJ, Hernandez AV, Donskey CJ. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. <i>J Antimicrob Chemother</i>. 2013;68(9):1951-1961. doi:10.1093/jac/dkt129<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23620467/pubmed" id="23620467" target="_blank">23620467</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29617685">
<a name="29617685"></a>Dibek Misirlioglu E, Guvenir H, Ozkaya Parlakay A, et al. Incidence of antibiotic-related rash in children with Epstein-Barr virus infection and evaluation of the frequency of confirmed antibiotic hypersensitivity. <i>Int Arch Allergy Immunol</i>. 2018;176(1):33-38. doi:10.1159/000481988<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29617685/pubmed" id="29617685" target="_blank">29617685</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9951971">
<a name="9951971"></a>Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant <i>Streptococcus pneumoniae</i> Therapeutic Working Group. <i>Pediatr Infect Dis J</i>. 1999;18(1):1-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/9951971/pubmed" id="9951971" target="_blank">9951971</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10904192">
<a name="10904192"></a>Dubois J, St-Pierre C. In vitro study of the post-antibiotic effect and the bactericidal activity of Cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens. <i>Diagn Microbiol Infect Dis</i>. 2000;37(3):187-193. doi:10.1016/s0732-8893(00)00141-3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/10904192/pubmed" id="10904192" target="_blank">10904192</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12534334">
<a name="12534334"></a>Easton J, Noble S, Perry CM. Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media. <i>Drugs</i>. 2003;63(3):311-340. doi:10.2165/00003495-200363030-00005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/12534334/pubmed" id="12534334" target="_blank">12534334</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Expert.DOR">
<a name="Expert.DOR"></a>Expert opinion. Senior Renal Editorial Team: Bruce Mueller, PharmD, FCCP, FASN, FNKF; Jason A. Roberts, PhD, BPharm (Hons), B App Sc, FSHP, FISAC; Michael Heung, MD, MS.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-File.1">
<a name="File.1"></a>File TM. Treatment of community-acquired pneumonia in adults who require hospitalization. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed December 16, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6660847">
<a name="6660847"></a>Fleisher GR, Wilmott CM, Campos JM. Amoxicillin combined with clavulanic acid for the treatment of soft tissue infections in children. <i>Antimicrob Agents Chemother</i>. 1983;24(5):679-681. doi:10.1128/AAC.24.5.679<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/6660847/pubmed" id="6660847" target="_blank">6660847</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16187174">
<a name="16187174"></a>Fontana RJ, Shakil AO, Greenson JK, Boyd I, Lee WM. Acute liver failure due to amoxicillin and amoxicillin/clavulanate. <i>Dig Dis Sci</i>. 2005;50(10):1785-1790. doi:10.1007/s10620-005-2938-5<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/16187174/pubmed" id="16187174" target="_blank">16187174</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25418487">
<a name="25418487"></a>Foureau DM, Walling TL, Maddukuri V, et al. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis. <i>Clin Exp Immunol</i>. 2015;180(1):40-51. doi:10.1111/cei.12558<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25418487/pubmed" id="25418487" target="_blank">25418487</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32364593">
<a name="32364593"></a>Fox MT, Amoah J, Hsu AJ, Herzke CA, Gerber JS, Tamma PD. Comparative effectiveness of antibiotic treatment duration in children with pyelonephritis. <i>JAMA Netw Open</i>. 2020;3(5):e203951. doi:10.1001/jamanetworkopen.2020.3951<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32364593/pubmed" id="32364593" target="_blank">32364593</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-445959">
<a name="445959"></a>Francke EL, Appel GB, Neu HC. Kinetics of intravenous amoxicillin in patients on long-term dialysis. <i>Clin Pharmacol Ther</i>. 1979;26(1):31-35. doi:10.1002/cpt197926131<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/445959/pubmed" id="445959" target="_blank">445959</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10423464">
<a name="10423464"></a>Freifeld A, Marchigiani D, Walsh T, et al; Infectious Diseases Society of America. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. <i>N Engl J Med</i>. 1999;341(5):305-311.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/10423464/pubmed" id="10423464" target="_blank">10423464</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21258094">
<a name="21258094"></a>Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2011;52(4):e56-93. doi:10.1093/cid/cir073<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21258094/pubmed" id="21258094" target="_blank">21258094</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32101171">
<a name="32101171"></a>Freundt Serpa NP, Sánchez-Morillas L, Jaqueti Moreno P, González-Gutiérrez ML, Cimarra M, Cerecedo I, Fernández-Rivas M. Drug-induced Enterocolitis Syndrome due to amoxicillin-clavulanic acid with good tolerance to penicillin. <i>J Investig Allergol Clin Immuno</i>l. 2020;30(4):301-302. doi: 10.18176/jiaci.0500<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32101171/pubmed" id="32101171" target="_blank">32101171</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27005794">
<a name="27005794"></a>Gaibino N, Bigotte Vieira M, Filipe P, Oliveira A. Acute generalised exanthematous pustulosis due to amoxicillin-clavulanate. <i>BMJ Case Rep</i>. 2016;2016:bcr2015213839. doi:10.1136/bcr-2015-213839<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27005794/pubmed" id="27005794" target="_blank">27005794</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30777258">
<a name="30777258"></a>Galli L, Venturini E, Bassi A, et al. Common community-acquired bacterial skin and soft-tissue infections in children: an intersociety consensus on impetigo, abscess, and cellulitis treatment. <i>Clin Ther</i>. 2019;41(3):532-551.e17. doi:10.1016/j.clinthera.2019.01.010<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30777258/pubmed" id="30777258" target="_blank">30777258</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15286214">
<a name="15286214"></a>Garbutt J, St Geme JW 3rd, May A, Storch GA, Shackelford PG. Developing community-specific recommendations for first-line treatment of acute otitis media: is high-dose amoxicillin necessary? <i>Pediatrics</i>. 2004;114(2):342-347. doi:10.1542/peds.114.2.342<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/15286214/pubmed" id="15286214" target="_blank">15286214</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11548760">
<a name="11548760"></a>Garcia-López M, Martinez-Blanco M, Martinez-Mir I, Palop V. Amoxycillin-clavulanic acid-related tooth discoloration in children. <i>Pediatrics</i>. 2001;108(3):819. doi:10.1542/peds.108.3.819-a<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/11548760/pubmed" id="11548760" target="_blank">11548760</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8651842">
<a name="8651842"></a>García Rodríguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. <i>Arch Intern Med</i>. 1996;156(12):1327-32. doi: 10.1001/archinte.1996.00440110099013<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/8651842/pubmed" id="8651842" target="_blank">8651842</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16312619">
<a name="16312619"></a>Gerlach KL, Schaal KP, Walz C, Pape HD. Treatment of severe odontogenic infections with amoxicillin/clavulanic acid. <i>J Chemother</i>. 1989;1(4)(suppl):746-747.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/16312619/pubmed" id="16312619" target="_blank">16312619</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26104506">
<a name="26104506"></a>Gillespie D, Hood K, Bayer A, et al. Antibiotic prescribing and associated diarrhoea: a prospective cohort study of care home residents. <i>Age Ageing</i>. 2015;44(5):853-60. doi:10.1093/ageing/afv072<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26104506/pubmed" id="26104506" target="_blank">26104506</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25404399">
<a name="25404399"></a>Gillies M, Ranakusuma A, Hoffmann T, et al. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. <i>CMAJ</i>. 2015;187(1):E21-E31. doi: 10.1503/cmaj.140848<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25404399/pubmed" id="25404399" target="_blank">25404399</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Gold.2021">
<a name="Gold.2021"></a>Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2022 report. https://goldcopd.org/2023-gold-report-2/. Updated 2023. Accessed January 30, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32434733">
<a name="32434733"></a>González Plo D, Plá Sánchez P, León Gámez CL, et al Update on the management of uncomplicated acute diverticulitis at our centre. Equally effective, more efficient. <i>Gastroenterol Hepatol.</i> 2020;43(8):426-430. doi:10.1016/j.gastrohep.2020.01.006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32434733/pubmed" id="32434733" target="_blank">32434733</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31039287">
<a name="31039287"></a>Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. <i>Cochrane Database Syst Rev</i>. 2019;4(4):CD004827. doi:10.1002/14651858.CD004827.pub5<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31039287/pubmed" id="31039287" target="_blank">31039287</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hooton.2018a">
<a name="Hooton.2018a"></a>Gupta K. Acute uncomplicated cystitis in females. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 4, 2023a.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hooton.2018b">
<a name="Hooton.2018b"></a>Gupta K. Acute complicated urinary tract infection (including pyelonephritis) in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 4, 2023b.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21292654">
<a name="21292654"></a>Gupta K, Hooton TM, Naber KG, et al; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. <i>Clin Infect Dis</i>. 2011;52(5):e103-e120.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21292654/pubmed" id="21292654" target="_blank">21292654</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Harper.2018">
<a name="Harper.2018"></a>Harper M. Clinical manifestations and initial management of bite wounds. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 8, 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17101020">
<a name="17101020"></a>Harries MJ, McIntyre SJ, Kingston TP. Co-amoxiclav-induced acute generalized exanthematous pustulosis confirmed by patch testing. <i>Contact Dermatitis</i>. 2006;55(6):372. doi:10.1111/j.1600-0536.2006.00929.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/17101020/pubmed" id="17101020" target="_blank">17101020</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26785402">
<a name="26785402"></a>Harris AM, Hicks LA, Qaseem A; High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. <i>Ann Intern Med</i>. 2016;164(6):425-434. doi:10.7326/M15-1840<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26785402/pubmed" id="26785402" target="_blank">26785402</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25250996">
<a name="25250996"></a>Hartman-Adams H, Banvard C, Juckette G. Impetigo: diagnosis and treatment. <i>Am Fam Physician</i>. 2014;90(4):229-235.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25250996/pubmed" id="25250996" target="_blank">25250996</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19209277">
<a name="19209277"></a>Hedge DD, Strain JD, Heins JR, Farver DK. New advances in the treatment of <i>Clostridium difficile</i> infection (CDI). <i>Ther Clin Risk Manag</i>. 2008;4(5):949-64. doi:10.2147/tcrm.s3145<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19209277/pubmed" id="19209277" target="_blank">19209277</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22146873">
<a name="22146873"></a>Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for <i>Clostridium difficile</i> infection after exposure to antibiotics. <i>J Antimicrob Chemother</i>. 2012;67(3):742-748. doi:10.1093/jac/dkr508<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22146873/pubmed" id="22146873" target="_blank">22146873</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16971233">
<a name="16971233"></a>Hernández-Salazar A, Rosales SP, Rangel-Frausto S, Criollo E, Archer-Dubon C, Orozco-Topete R. Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients. <i>Arch Med Res</i>. 2006;37(7):899-902. doi:10.1016/j.arcmed.2006.03.010<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/16971233/pubmed" id="16971233" target="_blank">16971233</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31321789">
<a name="31321789"></a>Hioki T, Kamiya K, Tsuda H, et al. Acute generalized exanthematous pustulosis induced by amoxicillin/clavulanic acid, manifesting as severe laryngeal edema. <i>J Dermatol</i>. 2019;46(11):e443-e444. doi:10.1111/1346-8138.15016<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31321789/pubmed" id="31321789" target="_blank">31321789</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9154538">
<a name="9154538"></a>Hoberman A, Paradise JL, Burch DJ, et al. Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children. <i>Pediatr Infect Dis J</i>. 1997;16(5):463-470. doi:10.1097/00006454-199705000-00002<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/9154538/pubmed" id="9154538" target="_blank">9154538</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28438923">
<a name="28438923"></a>Hoberman A, Paradise JL, Rockette HE, et al. Reduced-concentration clavulanate for young children with acute otitis media. <i>Antimicrob Agents Chemother</i>. 2017;61(7):e00238-17. doi:10.1128/AAC.00238-17<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28438923/pubmed" id="28438923" target="_blank">28438923</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28002709">
<a name="28002709"></a>Hoberman A, Paradise JL, Rockette HE, et al. Shortened antimicrobial treatment for acute otitis media in young children. <i>N Engl J Med</i>. 2016;375(25):2446-2456. doi:10.1056/NEJMoa1606043<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28002709/pubmed" id="28002709" target="_blank">28002709</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9798020">
<a name="9798020"></a>Högenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanisms and management of antibiotic-associated diarrhea. <i>Clin Infect Dis</i>. 1998;27(4):702-10. doi:10.1086/514958<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/9798020/pubmed" id="9798020" target="_blank">9798020</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31505007">
<a name="31505007"></a>Homme JH. Acute otitis media and group A streptococcal pharyngitis: a review for the general pediatric practitioner. <i>Pediatr Ann</i>. 2019;48(9):e343-e348. doi:10.3928/19382359-20190813-01<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31505007/pubmed" id="31505007" target="_blank">31505007</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15728165">
<a name="15728165"></a>Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. <i>JAMA</i> 2005;293(8):949-955. doi:10.1001/jama.293.8.949<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/15728165/pubmed" id="15728165" target="_blank">15728165</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3707111">
<a name="3707111"></a>Horber FF, Frey FJ, Descoeudres C, Murray AT, Reubi FC. Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin. <i>Antimicrob Agents Chemother.</i> 1986;29(4):614-619. doi:10.1128/aac.29.4.614<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/3707111/pubmed" id="3707111" target="_blank">3707111</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28502697">
<a name="28502697"></a>Hui K, Patel K, Kong DCM, Kirkpatrick CMJ. Impact of high-flux haemodialysis on the probability of target attainment for oral amoxicillin/clavulanic acid combination therapy. <i>Int J Antimicrob Agents</i>. 2017;50(1):110-113. doi:10.1016/j.ijantimicag.2017.02.021<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28502697/pubmed" id="28502697" target="_blank">28502697</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31561959">
<a name="31561959"></a>Hum SW, Shaikh KJ, Musa SS, Shaikh N. Adverse events of antibiotics used to treat acute otitis media in children: a systematic meta-analysis. <i>J Pediatr</i>. 2019;215:139-143.e7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31561959/pubmed" id="31561959" target="_blank">31561959</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21334779">
<a name="21334779"></a>Isla A, Trocóniz IF, Canut A, et al. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain. <i>Enferm Infecc Microbiol Clin</i>. 2011;29(3):167-173. doi:10.1016/j.eimc.2010.05.008<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21334779/pubmed" id="21334779" target="_blank">21334779</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10891521">
<a name="10891521"></a>Ito S. Drug therapy for breast-feeding women. <i>N Engl J Med</i>. 2000;343(2):118-126.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/10891521/pubmed" id="10891521" target="_blank">10891521</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29298155">
<a name="29298155"></a>Johnson JR, Russo TA. Acute pyelonephritis in adults [published correction appears in <i>N Engl J Med</i>. 2018;378(11):1069]. <i>N Engl J Med</i>. 2018;378(1):48-59.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29298155/pubmed" id="29298155" target="_blank">29298155</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3135377">
<a name="3135377"></a>Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. <i>J Pediatr</i>. 1988;113(2):400-403. doi:10.1016/s0022-3476(88)80291-9<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/3135377/pubmed" id="3135377" target="_blank">3135377</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35355215">
<a name="35355215"></a>Keij FM, Tramper-Stranders GA, Koch BCP, et al. Pharmacokinetics of clavulanic acid in the pediatric population: a systematic literature review. <i>Clin Pharmacokinet</i>. 2022;61(5):637-653. doi:10.1007/s40262-022-01116-3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/35355215/pubmed" id="35355215" target="_blank">35355215</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11293640">
<a name="11293640"></a>Kenyon SL, Taylor DJ, Tarnow-Mordi W; ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. <i>Lancet</i>. 2001;357(9261):979-988. doi:10.1016/s0140-6736(00)04233-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/11293640/pubmed" id="11293640" target="_blank">11293640</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10423465">
<a name="10423465"></a>Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. <i>N Engl J Med</i>. 1999;341(5):312-318.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/10423465/pubmed" id="10423465" target="_blank">10423465</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23358983">
<a name="23358983"></a>Kern WV, Marchetti O, Drgona L, et al. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy—EORTC Infectious Diseases Group trial XV. <i>J Clin Oncol</i>. 2013;31(9):1149-1156. doi:10.1200/JCO.2012.45.8109<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23358983/pubmed" id="23358983" target="_blank">23358983</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bartlett.2019">
<a name="Bartlett.2019"></a>Klompas M. Aspiration pneumonia in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 4, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31097213">
<a name="31097213"></a>Knight M, Chiocchia V, Partlett C, et al. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial. <i>Lancet</i>. 2019;393(10189):2395-2403. doi:10.1016/S0140-6736(19)30773-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31097213/pubmed" id="31097213" target="_blank">31097213</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20824827">
<a name="20824827"></a>Kozyrskyj A, Klassen TP, Moffatt M, Harvey K. Short-course antibiotics for acute otitis media. <i>Cochrane Database Syst Rev</i>. 2010;2010(9):CD001095. doi:10.1002/14651858.CD001095.pub2<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/20824827/pubmed" id="20824827" target="_blank">20824827</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6600085">
<a name="6600085"></a>Ksiazek A, Twardowski Z, Przyborowski L, et al. Pharmacokinetics of amoxycillin and ampicillin in patients with renal failure. <i>Ann Univ Mariae Curie Sklodowska Med.</i> 1983;38:79-86.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/6600085/pubmed" id="6600085" target="_blank">6600085</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35579504">
<a name="35579504"></a>Kuitunen I, Jääskeläinen J, Korppi M, Renko M. Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries - a systematic review and meta-analysis. <i>Clin Infect Dis</i>. 2022;ciac374. doi:10.1093/cid/ciac374<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/35579504/pubmed" id="35579504" target="_blank">35579504</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25189188">
<a name="25189188"></a>Lamont HF, Blogg HJ, Lamont RF. Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity. <i>Expert Opin Drug Saf</i>. 2014;13(12):1569-1581. doi:10.1517/14740338.2014.939580<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25189188/pubmed" id="25189188" target="_blank">25189188</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34860955">
<a name="34860955"></a>Lashkar MO, Nahata MC. Antimicrobial pharmacotherapy management of urinary tract infections in pediatric patients. <i>J Pharm Technol</i>. 2018;34(2):62-81. doi:10.1177/8755122518755402<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/34860955/pubmed" id="34860955" target="_blank">34860955</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4618910">
<a name="4618910"></a>Lawson DH, Henderson AK, McGeachy RR. Amoxycillin: pharmacokinetic studies in normal subjects, patients with pernicious anaemia and those with renal failure. <i>Postgrad Med J.</i> 1974;50(586):500-503. doi:10.1136/pgmj.50.586.500<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/4618910/pubmed" id="4618910" target="_blank">4618910</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26942743">
<a name="26942743"></a>Lepelletier D, Pinaud V, Le Conte P, et al; French PTA Study Group. Peritonsillar abscess (PTA): clinical characteristics, microbiology, drug exposures and outcomes of a large multicenter cohort survey of 412 patients hospitalized in 13 French university hospitals. <i>Eur J Clin Microbiol Infect Dis</i>. 2016;35(5):867-873. doi:10.1007/s10096-016-2609-9<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26942743/pubmed" id="26942743" target="_blank">26942743</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26941560">
<a name="26941560"></a>Le Saux N, Robinson JL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Management of acute otitis media in children six months of age and older. <i>Paediatr Child Health</i>. 2016;21(1):39-50. doi:10.1093/pch/21.1.39<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26941560/pubmed" id="26941560" target="_blank">26941560</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32215906">
<a name="32215906"></a>Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Antibiotic prophylaxis for operative vaginal delivery. <i>Cochrane Database Syst Rev</i>. 2020;3(3):CD004455. doi:10.1002/14651858.CD004455.pub5<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32215906/pubmed" id="32215906" target="_blank">32215906</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23439909">
<a name="23439909"></a>Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. <i>Pediatrics</i>. 2013;131(3):e964-e999.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23439909/pubmed" id="23439909" target="_blank">23439909</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Limb.2019">
<a name="Limb.2019"></a>Limb CJ, Lustig LR, Durand ML. Acute otitis media in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 4, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23171644">
<a name="23171644"></a>Lipsitz R, Garges S, Aurigemma R, et al. Workshop on treatment of and postexposure prophylaxis for <i>Burkholderia pseudomallei</i> and <i>B. mallei Infection</i>, 2010. <i>Emerg Infect Dis</i>. 2012;18(12):e2.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23171644/pubmed" id="23171644" target="_blank">23171644</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14679443">
<a name="14679443"></a>Lipsky BA, Itani K, Norden C; Linezolid Diabetic Foot Infections Study Group. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. <i>Clin Infect Dis</i>. 2004;38(1):17-24.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/14679443/pubmed" id="14679443" target="_blank">14679443</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22619242">
<a name="22619242"></a>Lipsky BA, Berendt AR, Cornia PB, et al; Infectious Diseases Society of America. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. <i>Clin Infect Dis.</i> 2012;54(12):e132-e173. doi:10.1093/cid/cis346<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22619242/pubmed" id="22619242" target="_blank">22619242</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30020891">
<a name="30020891"></a>Litao G, Jingjing S, Yu L, Lei Z, Xiaona H, Zhijing Z. Risk factors for antibiotic-associated diarrhea in critically ill patients. <i>Med Sci Monit</i>. 2018;24:5000-5007. doi:10.12659/MSM.911308<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30020891/pubmed" id="30020891" target="_blank">30020891</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22923662">
<a name="22923662"></a>Llor C, Moragas A, Hernández S, Bayona C, Miravitlles M. Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease. <i>Am J Respir Crit Care Med.</i> 2012;186(8):716-723.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22923662/pubmed" id="22923662" target="_blank">22923662</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18555934">
<a name="18555934"></a>Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. <i>Clin Ther</i>. 2008;30(5):868-883. doi:10.1016/j.clinthera.2008.04.019<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/18555934/pubmed" id="18555934" target="_blank">18555934</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21570397">
<a name="21570397"></a>Lucena MI, Molokhia M, Shen Y, et al; Spanish DILI Registry; EUDRAGENE; DILIN; DILIGEN; International SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. <i>Gastroenterology</i>. 2011;141(1):338-347. doi:10.1053/j.gastro.2011.04.001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21570397/pubmed" id="21570397" target="_blank">21570397</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31118710">
<a name="31118710"></a>Ma H, Zhang L, Zhang Y, Liu Y, He Y, Guo L. Combined administration of antibiotics increases the incidence of antibiotic-associated diarrhea in critically ill patients. <i>Infect Drug Resist</i>. 2019;12:1047-1054. doi:10.2147/IDR.S194715<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31118710/pubmed" id="31118710" target="_blank">31118710</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3670959">
<a name="3670959"></a>Macknin ML. Behavioral changes after amoxicillin-clavulanate. <i>Pediatr Infect Dis J</i>. 1987;6(9):873-874. doi:10.1097/000367095906454-198709000-00024<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/3670959/pubmed" id="3670959" target="_blank">3670959</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17278083">
<a name="17278083"></a>Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. <i>Clin Infect Dis</i>. 2007;44(suppl 2):S27-S72.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/17278083/pubmed" id="17278083" target="_blank">17278083</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25477568">
<a name="25477568"></a>Mansour H, Saad A, Azar M, Khoueiry P. Amoxicillin/Clavulanic acid-induced thrombocytopenia. <i>Hosp Pharm</i>. 2014;49(10):956-960. doi:10.1310/hpj4910-956<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25477568/pubmed" id="25477568" target="_blank">25477568</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16490583">
<a name="16490583"></a>Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. <i>Clin Ther</i>. 2006;28(1):99-109.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/16490583/pubmed" id="16490583" target="_blank">16490583</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31876601">
<a name="31876601"></a>Marchisio P, Galli L, Bortone B, et al. Updated guidelines for the management of acute otitis media in children by the Italian Society of Pediatrics: treatment. <i>Pediatr Infect Dis J</i>. 2019;38(12S suppl):S10-S21. doi:10.1097/INF.0000000000002452<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31876601/pubmed" id="31876601" target="_blank">31876601</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8393108">
<a name="8393108"></a>Matisko MW, Bissada NF. Short-term sequential administration of amoxicillin/clavulanate potassium and doxycycline in the treatment of recurrent/progressive periodontitis. <i>J Periodontol</i>. 1993;64(6):553-558. doi:10.1902/jop.1993.64.6.553<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/8393108/pubmed" id="8393108" target="_blank">8393108</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28085573">
<a name="28085573"></a>Mazuski JE, Tessier JM, May AK, et al. The Surgical Infection Society revised guidelines on the management of intra-abdominal infection. <i>Surg Infect (Larchmt)</i>. 2017;18(1):1-76. doi:10.1089/sur.2016.261<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28085573/pubmed" id="28085573" target="_blank">28085573</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29462280">
<a name="29462280"></a>McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for <i>Clostridium difficile</i> Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). <i>Clin Infect Dis</i>. 2018;66(7):e1-e48. doi:10.1093/cid/cix1085<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29462280/pubmed" id="29462280" target="_blank">29462280</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18811240">
<a name="18811240"></a>McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. <i>Future Microbiol</i>. 2008;3(5):563-578. doi:10.2217/17460913.3.5.563<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/18811240/pubmed" id="18811240" target="_blank">18811240</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27003987">
<a name="27003987"></a>McFarland LV, Ozen M, Dinleyici EC, Goh S. Comparison of pediatric and adult antibiotic-associated diarrhea and <i>Clostridium difficile</i> infections. <i>World J Gastroenterol</i>. 2016;22(11):3078-3104. doi:10.3748/wjg.v22.i11.3078<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27003987/pubmed" id="27003987" target="_blank">27003987</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31573350">
<a name="31573350"></a>Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. <i>Am J Resp Crit Care Med</i>. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581ST<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31573350/pubmed" id="31573350" target="_blank">31573350</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31699837">
<a name="31699837"></a>Middleton PG, Gade EJ, Aguilera C, et al. ERS/TSANZ Task Force statement on the management of reproduction and pregnancy in women with airways diseases. <i>Eur Respir J</i>. 2020;55(2):1901208. doi:10.1183/13993003.01208-2019<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31699837/pubmed" id="31699837" target="_blank">31699837</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11806623">
<a name="11806623"></a>Mira E, Benazzo M. A multicenter study on the clinical efficacy and safety of roxithromycin in the treatment of ear-nose-throat infections: comparison with amoxycillin/clavulanic acid. <i>J Chemother</i>. 2001;13(6):621-627.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/11806623/pubmed" id="11806623" target="_blank">11806623</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32171559">
<a name="32171559"></a>Miranda-Katz M, Parmar D, Dang R, Alabaster A, Greenhow TL. Epidemiology and risk factors for community associated <i>Clostridioides difficile</i> in children. <i>J Pediatr</i>. 2020;221:99-106. doi: 10.1016/j.jpeds.2020.02.005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32171559/pubmed" id="32171559" target="_blank">32171559</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31419012">
<a name="31419012"></a>Moloney N, Paget S, Keijzers G. Kounis syndrome: Anaphylaxis causing coronary occlusion. <i>Emerg Med Australas</i>. 2019;31(5):903-905. doi: 10.1111/1742-6723.13377<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31419012/pubmed" id="31419012" target="_blank">31419012</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34183510">
<a name="34183510"></a>Mora-López L, Ruiz-Edo N, Estrada-Ferrer O, et al; DINAMO-study Group. Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO-study): a multicentre, randomised, open-label, noninferiority trial. <i>Ann Surg.</i> 2021;274(5):e435-e442. doi:10.1097/SLA.0000000000005031<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/34183510/pubmed" id="34183510" target="_blank">34183510</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24192258">
<a name="24192258"></a>Mora Lopez L, Serra Pla S, Serra-Aracil X, Ballesteros E, Navarro S. Application of a modified Neff classification to patients with uncomplicated diverticulitis. <i>Colorectal Dis</i>. 2013;15(11):1442-1447. doi:10.1111/codi.12449<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/24192258/pubmed" id="24192258" target="_blank">24192258</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28599076">
<a name="28599076"></a>Mori F, Fili L, Barni S, et al. T-cell activation in two cases of Stevens-Johnson syndrome after receiving amoxicillin-clavulanic acid. <i>Pediatr Allergy Immunol</i>. 2017;28(6):602-606. doi:10.1111/pai.12741<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28599076/pubmed" id="28599076" target="_blank">28599076</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28722171">
<a name="28722171"></a>Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. <i>Br J Clin Pharmacol</i>. 2017a;83(11):2557-2571. doi:10.1111/bcp.13364<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28722171/pubmed" id="28722171" target="_blank">28722171</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28461374">
<a name="28461374"></a>Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. <i>CMAJ</i>. 2017b;189(17):E625-E633. doi:10.1503/cmaj.161020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28461374/pubmed" id="28461374" target="_blank">28461374</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19164154">
<a name="19164154"></a>Muller AE, Oostvogel PM, DeJongh J, et al. Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera. <i>Antimicrob Agents Chemother</i>. 2009;53(4):1574-1580. doi:10.1128/AAC.00119-08<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19164154/pubmed" id="19164154" target="_blank">19164154</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29858434">
<a name="29858434"></a>Mullish BH, Williams HR. <i>Clostridium difficile</i> infection and antibiotic-associated diarrhoea. <i>Clin Med (Lond)</i>. 2018;18(3):237-241. doi:10.7861/clinmedicine.18-3-237<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29858434/pubmed" id="29858434" target="_blank">29858434</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29408016">
<a name="29408016"></a>Nasiri MJ, Goudarzi M, Hajikhani B, Ghazi M, Goudarzi H, Pouriran R. Clostridioides (Clostridium) difficile infection in hospitalized patients with antibiotic-associated diarrhea: A systematic review and meta-analysis. <i>Anaerobe</i>. 2018;50:32-37. doi:10.1016/j.anaerobe.2018.01.011<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29408016/pubmed" id="29408016" target="_blank">29408016</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NICE.2014">
<a name="NICE.2014"></a>National Institute for Health and Care Excellence (NICE). Drug allergy: Diagnosis and management (CG183). https://www.nice.org.uk/guidance/cg183. Published September 3, 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NICE.1">
<a name="NICE.1"></a>National Institute for Health and Care Excellence (NICE). Otitis media (acute): antimicrobial prescribing. London, UK: National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng91. Published March 2018. Accessed November 3, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NICE.2017">
<a name="NICE.2017"></a>National Institute for Health and Care Excellence (NICE). Sinusitis (acute): antimicrobial prescribing. London, UK: National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng79. Published October 2017. Accessed January 25, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11709352">
<a name="11709352"></a>Neuhauser MM, Prause JL, Danziger LH, Pendland SL. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. <i>Antimicrob Agents Chemother.</i> 2001;45(12):3613-3615. doi:10.1128/AAC.45.12.3613-3615.2001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/11709352/pubmed" id="11709352" target="_blank">11709352</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31506700">
<a name="31506700"></a>Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2019;68(10):1611-1615. doi:10.1093/cid/ciz021<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31506700/pubmed" id="31506700" target="_blank">31506700</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23223583">
<a name="23223583"></a>Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2013;56(1):e1-e25.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23223583/pubmed" id="23223583" target="_blank">23223583</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19702992">
<a name="19702992"></a>Panasiti V, Rossi M, Devirgiliis V, Curzio M, Bottoni U, Calvieri S. Amoxicillin-clavulanic acid-induced linear immunoglobulin A bullous dermatosis: case report and review of the literature. <i>Int J Dermatol</i>. 2009;48(9):1006-10. doi:10.1111/j.1365-4632.2009.04104.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19702992/pubmed" id="19702992" target="_blank">19702992</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27756758">
<a name="27756758"></a>Patterson-Fortin J, Harris CM, Niranjan-Azadi A, Melia M. Serum sickness-like reaction after the treatment of cellulitis with amoxicillin/clavulanate. <i>BMJ Case Rep</i>. 2016;2016:bcr2016217608. doi: 10.1136/bcr-2016-217608<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27756758/pubmed" id="27756758" target="_blank">27756758</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17385141">
<a name="17385141"></a>Peled N, Pitlik S, Samra Z, Kazakov A, Bloch Y, Bishara J. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea. <i>Infect Control Hosp Epidemiol</i>. 2007;28(4):377-381. doi:10.1086/513723<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/17385141/pubmed" id="17385141" target="_blank">17385141</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Pemberton.1">
<a name="Pemberton.1"></a>Pemberton JH. Acute colonic diverticulitis: medical management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed April 13, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22690011">
<a name="22690011"></a>Peng CZ, How CK. Erythema multiforme following antibiotic therapy for pneumonia. <i>QJM</i>. 2013;106(6):585-6. doi: 10.1093/qjmed/hcs104<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22690011/pubmed" id="22690011" target="_blank">22690011</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20946462">
<a name="20946462"></a>Pérez-Ezquerra PR, Sanchez-Morillas L, Alvarez AS, Gómez-Tembleque MP, Moratiel HB, Martinez JJ. Fixed drug eruption caused by amoxicillin-clavulanic acid. <i>Contact Dermatitis</i>. 2010;63(5):294-296. doi:10.1111/j.1600-0536.2010.01802.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/20946462/pubmed" id="20946462" target="_blank">20946462</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33683325">
<a name="33683325"></a>Pernica JM, Harman S, Kam AJ, et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: the SAFER Randomized Clinical Trial. <i>JAMA Pediatr</i>. 2021;175(5):475-482. doi:10.1001/jamapediatrics.2020.6735<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/33683325/pubmed" id="33683325" target="_blank">33683325</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25825185">
<a name="25825185"></a>Pherwani N, Ghayad JM, Holle LM, Karpiuk EL. Outpatient management of febrile neutropenia associated with cancer chemotherapy: risk stratification and treatment review. <i>Am J Health Syst Pharm</i>. 2015;72(8):619-613.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25825185/pubmed" id="25825185" target="_blank">25825185</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31924232">
<a name="31924232"></a>Piccorossi A, Liccioli G, Barni S, et al. Epidemiology and drug allergy results in children investigated in allergy unit of a tertiary-care paediatric hospital setting. <i>Ital J Pediatr</i>. 2020;46(1):5. doi:10.1186/s13052-019-0753-4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31924232/pubmed" id="31924232" target="_blank">31924232</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19014842">
<a name="19014842"></a>Poachanukoon O, Kitcharoensakkul M. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial. <i>Clin Ther</i>. 2008;30(10):1870-1879. doi:10.1016/j.clinthera.2008.10.001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19014842/pubmed" id="19014842" target="_blank">19014842</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30298362">
<a name="30298362"></a>Rodríguez-Martín S, Martín-Merino E, Lerma V, et al. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. <i>Eur J Clin Pharmacol</i>. 2019;75(2):237-246. doi:10.1007/s00228-018-2569-3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30298362/pubmed" id="30298362" target="_blank">30298362</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27016799">
<a name="27016799"></a>Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Caruso C, Quaratino D. Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell-mediated hypersensitivity to penicillins. <i>J Allergy Clin Immunol</i>. 2016;138(1):179-186. doi:10.1016/j.jaci.2016.01.025<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27016799/pubmed" id="27016799" target="_blank">27016799</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29408440">
<a name="29408440"></a>Romano A, Valluzzi RL, Caruso C, Maggioletti M, Quaratino D, Gaeta F. Cross-Reactivity and Tolerability of Cephalosporins in Patients with IgE-Mediated Hypersensitivity to Penicillins. <i>J Allergy Clin Immunol Pract</i>. 2018;6(5):1662-1672. doi:10.1016/j.jaip.2018.01.020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29408440/pubmed" id="29408440" target="_blank">29408440</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25832968">
<a name="25832968"></a>Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. <i>Otolaryngol Head Neck Surg</i>. 2015;152(2)(suppl):S1-S39. doi:10.1177/0194599815572097<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25832968/pubmed" id="25832968" target="_blank">25832968</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28708801">
<a name="28708801"></a>Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, et al. Bone and joint infections. <i>Pediatr Infect Dis J</i>. 2017;36(8):788-799. doi:10.1097/INF.0000000000001635<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28708801/pubmed" id="28708801" target="_blank">28708801</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28342830">
<a name="28342830"></a>Salas M, Laguna JJ, Doña I, et al. Patients taking amoxicillin-clavulanic can become simultaneously sensitized to both drugs. <i>J Allergy Clin Immunol Pract</i>. 2017;5(3):694-702.e3. doi:10.1016/j.jaip.2017.02.007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28342830/pubmed" id="28342830" target="_blank">28342830</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17449881">
<a name="17449881"></a>Salvo F, Polimeni G, Moretti U, Conforti A, Leone R, Leoni O, Motola D, Dusi G, Caputi AP. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. <i>J Antimicrob Chemother</i>. 2007;60(1):121-6. doi: 10.1093/jac/dkm111<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/17449881/pubmed" id="17449881" target="_blank">17449881</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32525203">
<a name="32525203"></a>Same RG, Amoah J, Hsu AJ, et al. The association of antibiotic duration with successful treatment of community-acquired pneumonia in children. <i>J Pediatric Infect Dis Soc</i>. 2021;10(3):267-273. doi:10.1093/jpids/piaa055<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32525203/pubmed" id="32525203" target="_blank">32525203</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20434202">
<a name="20434202"></a>Sánchez-Morillas L, Pérez-Ezquerra PR, Reaño-Martos M, Laguna-Martínez JJ, Sanz ML, Martínez LM. Selective allergic reactions to clavulanic acid: a report of 9 cases. <i>J Allergy Clin Immunol</i>. 2010;126(1):177-9. doi:10.1016/j.jaci.2010.03.012<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/20434202/pubmed" id="20434202" target="_blank">20434202</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25992746">
<a name="25992746"></a>Sawyer RG, Claridge JA, Nathens AB, et al; STOP-IT Trial Investigators. Trial of short-course antimicrobial therapy for intraabdominal infection. <i>N Engl J Med.</i> 2015;372(21):1996-2005. doi:10.1056/NEJMoa1411162<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25992746/pubmed" id="25992746" target="_blank">25992746</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6838187">
<a name="6838187"></a>Schaad UB, Casey PA, Cooper DL. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. <i>Antimicrob Agents Chemother.</i> 1983;23(2):252-255. doi:10.1128/AAC.23.2.252<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/6838187/pubmed" id="6838187" target="_blank">6838187</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Sethi.2020">
<a name="Sethi.2020"></a>Sethi S, Murphy TF. Management of infection in exacerbations of chronic obstructive pulmonary disease. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 3, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28719679">
<a name="28719679"></a>Shah SD, Cifu AS. Management of acute diverticulitis. <i>JAMA</i>. 2017;318(3):291-292. doi:10.1001/jama.2017.6373<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/28719679/pubmed" id="28719679" target="_blank">28719679</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29053792">
<a name="29053792"></a>Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. <i>Clin Infect Dis</i>. 2017;65(12):e45-e80. doi:10.1093/cid/cix669<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29053792/pubmed" id="29053792" target="_blank">29053792</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22965026">
<a name="22965026"></a>Shulman ST, Bisno AL, Clegg HW, et al; Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. <i>Clin Infect Dis.</i> 2012;55(10):e86-e102. doi:10.1093/cid/cis629<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22965026/pubmed" id="22965026" target="_blank">22965026</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34118486">
<a name="34118486"></a>Siddiqui Z, Tahiri M, Gupta A, Kin Nam RH, Rachmanidou A. The management of paediatric rhinosinusitis. <i>Int J Pediatr Otorhinolaryngol</i>. 2021;147:110786. doi:10.1016/j.ijporl.2021.110786<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/34118486/pubmed" id="34118486" target="_blank">34118486</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24324224">
<a name="24324224"></a>Slimings C, Riley TV. Antibiotics and hospital-acquired <i>Clostridium difficile</i> infection: update of systematic review and meta-analysis. <i>J Antimicrob Chemother</i>. 2014;69(4):881-891. doi:10.1093/jac/dkt477<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/24324224/pubmed" id="24324224" target="_blank">24324224</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20034345">
<a name="20034345"></a>Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2010;50(2):133-164. doi:10.1086/649554<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/20034345/pubmed" id="20034345" target="_blank">20034345</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23663820">
<a name="23663820"></a>Sowerby LJ, Hussain Z, Husein M. The epidemiology, antibiotic resistance and post-discharge course of peritonsillar abscesses in London, Ontario. <i>J Otolaryngol Head Neck Surg</i>. 2013;42:5. doi:10.1186/1916-0216-42-5<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23663820/pubmed" id="23663820" target="_blank">23663820</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33419114">
<a name="33419114"></a>Spoială EL, Stanciu GD, Bild V, Ababei DC, Gavrilovici C. From evidence to clinical guidelines in antibiotic treatment in acute otitis media in children. <i>Antibiotics (Basel)</i>. 2021;10(1):52. doi:10.3390/antibiotics10010052<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/33419114/pubmed" id="33419114" target="_blank">33419114</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25477258">
<a name="25477258"></a>Stein R, Dogan HS, Hoebeke P, et al. Urinary tract infections in children: EAU/ESPU guidelines. <i>Eur Urol</i>. 2015;67(3):546-558. doi:10.1016/j.eururo.2014.11.007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/25477258/pubmed" id="25477258" target="_blank">25477258</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24973422">
<a name="24973422"></a>Stevens DL, Bisno AL, Chambers HF, et al; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2014;59(2):e10-e52. doi:10.1093/cid/ciu444<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/24973422/pubmed" id="24973422" target="_blank">24973422</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26453777">
<a name="26453777"></a>Stollman N, Smalley W, Hirano I; AGA Institute Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on the management of acute diverticulitis. <i>Gastroenterology</i>. 2015;149(7):1944-1949. doi:10.1053/j.gastro.2015.10.003<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26453777/pubmed" id="26453777" target="_blank">26453777</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21226577">
<a name="21226577"></a>Tähtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. <i>N Engl J Med</i>. 2011;364(2):116-126. doi:10.1056/NEJMoa1007174<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21226577/pubmed" id="21226577" target="_blank">21226577</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Takase.1982">
<a name="Takase.1982"></a>Takase Z, Shirafuji H, Uchida M. Clinical and Laboratory Studies on BRL25000 (Clavulanic acid-amoxicillin) in the field of obstetrics and gynecology. <i>Japanese Journal of Chemotherapy </i>1982;30(suppl 2):579-586.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26300919">
<a name="26300919"></a>Tancawan AL, Pato MN, Abidin KZ, et al. Amoxicillin/clavulanic acid for the treatment of odontogenic infections: a randomised study comparing efficacy and tolerability versus clindamycin [published online August 2, 2015]. <i>Int J Dent</i>. doi:10.1155/2015/472470<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26300919/pubmed" id="26300919" target="_blank">26300919</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29461916">
<a name="29461916"></a>Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. <i>J Clin Oncol</i>. 2018;36(14):1443-1453. doi:10.1200/JCO.2017.77.6211<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29461916/pubmed" id="29461916" target="_blank">29461916</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9124843">
<a name="9124843"></a>Thorburn CE, Molesworth SJ, Sutherland R, Rittenhouse S. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate. <i>Antimicrob Agents Chemother.</i> 1996;40(12):2796-2801. doi:10.1128/AAC.40.12.2796<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/9124843/pubmed" id="9124843" target="_blank">9124843</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2184003">
<a name="2184003"></a>Todd PA, Benfield P. Amoxicillin/Clavulanic Acid. An Update of Its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use. <i>Drugs</i>. 1990;39(2):264-307.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/2184003/pubmed" id="2184003" target="_blank">2184003</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26662186">
<a name="26662186"></a>Torres MJ, Montañez MI, Ariza A, et al. The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid. <i>Clin Exp Allergy</i>. 2016;46(2):264-274. doi:10.1111/cea.12689<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/26662186/pubmed" id="26662186" target="_blank">26662186</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19659645">
<a name="19659645"></a>Tsang KW, Bilton D. Clinical challenges in managing bronchiectasis. <i>Respirology</i>. 2009;14(5):637-650. doi:10.1111/j.1440-1843.2009.01569.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19659645/pubmed" id="19659645" target="_blank">19659645</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3400652">
<a name="3400652"></a>Tu YH, Stiles ML, Allen LV Jr, et al. Stability of Amoxicillin Trihydrate-Potassium Clavulanate in Original Containers and Unit Dose Oral Syringes. <i>Am J Hosp Pharm</i>. 1988;45(5):1092-1099.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/3400652/pubmed" id="3400652" target="_blank">3400652</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21696732">
<a name="21696732"></a>Usta TA, Dogan O, Ates U, Yucel B, Onar Z, Kaya E. Comparison of single-dose and multiple-dose antibiotics for lower urinary tract infection in pregnancy. <i>Int J Gynaecol Obstet</i>. 2011;114(3):229-233. doi:10.1016/j.ijgo.2011.03.014<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/21696732/pubmed" id="21696732" target="_blank">21696732</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32073652">
<a name="32073652"></a>van Dijk ST, Chabok A, Dijkgraaf MG, Boermeester MA, Smedh K. Observational versus antibiotic treatment for uncomplicated diverticulitis: an individual-patient data meta-analysis. <i>Br J Surg.</i> 2020;107(8):1062-1069. doi:10.1002/bjs.11465<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32073652/pubmed" id="32073652" target="_blank">32073652</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31034997">
<a name="31034997"></a>Van Gasse AL, Ebo DG, Chiriac AM, et al. The limited value of prolonged drug challenges in nonimmediate amoxicillin (clavulanic acid) hypersensitivity. <i>J Allergy Clin Immunol Pract</i>. 2019;7(7):2225-2229.e1. doi:10.1016/j.jaip.2019.04.021<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/31034997/pubmed" id="31034997" target="_blank">31034997</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29569759">
<a name="29569759"></a>van Kester MS, Langeveld TJC, Bouwsma H, et al. A breathtaking DRESS due to amoxicillin-clavulanate presenting as polymorphic eruption of the pregnancy. <i>J Eur Acad Dermatol Venereol</i>. 2018;32(12):e436-e437. doi:10.1111/jdv.14956<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29569759/pubmed" id="29569759" target="_blank">29569759</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3908124">
<a name="3908124"></a>van Niekerk CH, van den Ende J, Hundt HK, Louw EA. Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children. <i>Eur J Clin Pharmacol.</i> 1985;29(2):235-239. doi:10.1007/BF00547429<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/3908124/pubmed" id="3908124" target="_blank">3908124</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22418755">
<a name="22418755"></a>van Noord C, Wulkan RW, van den Dorpel MA. Crystalluria. <i>Neth J Med</i>. 2012;70(2):84, 87.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22418755/pubmed" id="22418755" target="_blank">22418755</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27216385">
<a name="27216385"></a>Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. <i>Clostridium difficile</i> infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. <i>Int J Antimicrob Agents</i>. 2016;48(1):1-10. doi:10.1016/j.ijantimicag.2016.03.008<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/27216385/pubmed" id="27216385" target="_blank">27216385</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32529182">
<a name="32529182"></a>Viloria-Alebesque A, Povar-Echeverría M, Bruscas-Alijarde MJ, Gracia-Gutiérrez A, Royo-Trallero L, Al-Cheikh-Felices P. Myoclonus induced by amoxicillin-clavulanic acid. <i>Epilepsy Behav Rep</i>. 2020;14:100367. doi:10.1016/j.ebr.2020.100367<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32529182/pubmed" id="32529182" target="_blank">32529182</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23796742">
<a name="23796742"></a>Wald ER, Applegate KE, Bordley C, et al; American Academy of Pediatrics. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. <i>Pediatrics</i>. 2013;132(1):e262-e280.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/23796742/pubmed" id="23796742" target="_blank">23796742</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Wald.2019">
<a name="Wald.2019"></a>Wald ER. Peritonsillar cellulitis and abscess. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 2, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19564277">
<a name="19564277"></a>Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. <i>Pediatrics</i>. 2009;124(1):9-15. doi:10.1542/peds.2008-2902<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/19564277/pubmed" id="19564277" target="_blank">19564277</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29272341">
<a name="29272341"></a>Watson T, Hickok J, Fraker S, Korwek K, Poland RE, Septimus E. Evaluating the risk factors for hospital-onset <i>Clostridium difficile</i> infections in a large healthcare system. <i>Clin Infect Dis</i>. 2018;66(12):1957-1959. doi:10.1093/cid/cix1112<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29272341/pubmed" id="29272341" target="_blank">29272341</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6739312">
<a name="6739312"></a>Weber DJ, Tolkoff-Rubin NE, Rubin RH. Amoxicillin and Potassium Clavulanate: An Antibiotic Combination. Mechanism of Action, Pharmacokinetics, Antimicrobial Spectrum, Clinical Efficacy and Adverse Effects. <i>Pharmacotherapy</i>. 1984;4(3):122-136.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/6739312/pubmed" id="6739312" target="_blank">6739312</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Weintrob.2018">
<a name="Weintrob.2018"></a>Weintrob AC, Sexton DJ. Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 4, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35040920">
<a name="35040920"></a>Williams DJ, Creech CB, Walter EB, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. <i>JAMA Pediatr</i>. 2022;176(3):253-261. doi:10.1001/jamapediatrics.2021.5547<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/35040920/pubmed" id="35040920" target="_blank">35040920</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22135277">
<a name="22135277"></a>Wilson R, Anzueto A, Miravitlles M, et al. Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. <i>Eur Respir J</i>. 2012;40(1):17-27. doi:10.1183/09031936.00090311<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/22135277/pubmed" id="22135277" target="_blank">22135277</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34350458">
<a name="34350458"></a>Woods CR, Bradley JS, Chatterjee A, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (PIDS/IDSA): 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. <i>J Pediatric Infect Dis Soc</i>. 2021;10(8):801-844. doi:10.1093/jpids/piab027<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/34350458/pubmed" id="34350458" target="_blank">34350458</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.2001">
<a name="WHO.2001"></a>World Health Organization (WHO). <i>WHO Model Prescribing Information: Drugs Used in Bacterial Infections</i>. Geneva, Switzerland: World Health Organization; 2001. http://apps.who.int/medicinedocs/pdf/s5406e/s5406e.pdf. Accessed November 6, 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.2002">
<a name="WHO.2002"></a>World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the Eleventh WHO Model List of Essential Drugs. 2002. http://www.who.int/maternal_child_adolescent/documents/55732/en/.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7489869">
<a name="7489869"></a>Wynn RL, Bergman SA. Antibiotics and Their Use in the Treatment of Orofacial Infections, Part I and Part II. <i>Gen Dent</i>. 1994;42(5):398-402, 498-502.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/7489869/pubmed" id="7489869" target="_blank">7489869</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30535100">
<a name="30535100"></a>Yahav D, Franceschini E, Koppel F, et al; Bacteremia Duration Study Group. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. <i>Clin Infect Dis</i>. 2019;69(7):1091-1098. doi:10.1093/cid/ciy1054<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/30535100/pubmed" id="30535100" target="_blank">30535100</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29713612">
<a name="29713612"></a>Youn Y, Lee SW, Cho HH, Park S, Chung HS, Seo JW. Antibiotics-associated hemorrhagic colitis caused by <i>Klebsiella oxytoca</i>: Two case reports. <i>Pediatr Gastroenterol Hepatol Nutr</i>. 2018;21(2):141-146. doi:10.5223/pghn.2018.21.2.141<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/29713612/pubmed" id="29713612" target="_blank">29713612</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-36112500">
<a name="36112500"></a>Yu D, Bio LL. Shedding light on amoxicillin, amoxicillin-clavulanate, and cephalexin dosing in children from a pharmacist's perspective. <i>J Pediatric Infect Dis Soc</i>. 2022;11(12):594-602. doi:10.1093/jpids/piac105<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/36112500/pubmed" id="36112500" target="_blank">36112500</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35170473">
<a name="35170473"></a>Yuksek T, Gönül M, Gökçe A. Drug-induced histiocytoid sweet syndrome: two cases with levofloxacin and amoxicillin-clavulanate. <i>Am J Dermatopathol</i>. 2022;44(5):380-383. doi:10.1097/DAD.0000000000002131<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/35170473/pubmed" id="35170473" target="_blank">35170473</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32518780">
<a name="32518780"></a>Zhou H, Xu Q, Liu Y, Guo LT. Risk factors, incidence, and morbidity associated with antibiotic-associated diarrhea in intensive care unit patients receiving antibiotic monotherapy. <i>World J Clin Cases</i>. 2020;8(10):1908-1915. doi:10.12998/wjcc.v8.i10.1908<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-and-clavulanate-pediatric-drug-information/abstract-text/32518780/pubmed" id="32518780" target="_blank">32518780</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12639 Version 516.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
